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Dear Reader,  
This combined thesis is composed of 2 separate research projects, undertaken for the 
award of Masters of Research in Molecular and Cellular Biology, at the University of 
Birmingham.  
Both projects focus on bacterial Nucleoside Diphosphate Kinase (NDK) proteins; and 
have many similarities. I have therefore consciously combined both projects so that 
they read as one with ease.  
Part A of this thesis focuses on the effects of bacterial NDK proteins on haemopoietic 
stem cells, derived from bone marrow and leukaemic samples. This project was 
supervised by Dr. Farhat Khanim at the School of Biosciences, College of Life and 
Environmental Sciences, University of Birmingham. 
 Part B of this thesis focuses on the characterisation of bacterial NDK proteins and 
determines whether point mutations or deletions within the conserved protein 
domains of NDK could affect the function of the protein. This project supervised by Dr. 
Mark Webber at the School of Immunity and Infection, College of Medical and Dental 







Nucleoside Diphosphate Kinases (NDK) are a family of small conserved proteins 
present in all cells which are involved in the synthesis of nucleoside triphosphates 
(NTP) and nucleoside diphosphates (NDP) which maintain nucleotide pools in the cell. 
NDK play an important role in the cells metabolic processes, for example maintaining 
dNTP for nucleic acid synthesis, CTPs for lipid synthesis, UTPs for polysaccharide 
synthesis and GTP for protein elongation. Most NDK proteins are known to form 
hexameric quaternary structure; however a few prokaryotic NDKs are tetrameric. 
However regardless of their quaternary structure all NDK proteins share a common 
dimer unit and the structures surrounding the active histidine site is identical in all 
NDK.  
The NDK protein found in humans named, non-metastatic 23 (NM23) was studied 
recently by Lily et al. A survival mechanistic role of the human NM23-H1 protein on 
haemopoietic stem cells was identified. It was shown that the NM23-H1 protein 
increased the survival and proliferation of stem cells from bone marrow and umbilical 
cord bloods and also acute myeloid leukaemia (AML).   
Hypothesis 
This study tested the hypothesis that bacterial NDK proteins can promote the survival 
of haemopoietic stem cells. Infection has been identified as a risk factor for 
progression to AML in patients with pre-leukaemic conditions. 
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Methods 
The over expression of bacterial NDK from four bacterial species; Escherichia coli, 
Klebsiella pneumonie, Staphylococcus aureus and Streptococcus pneumoniae, were 
cultured for 5 days with CD34-ve and CD34+ cells from umbilical cord bloods  and 
leukaemic samples. FACs analysis showed the cell viability of CD34-ve and CD34+ve 
stem cells. The expression of NDK at mid-logarithmic and at stationary phase were 
analysed, and NDK knockout mutants and site directed mutants were produced from 
conserved domains of the NDK, to characterise important domains which could play a 
role in the NDK survival mechanism on haemopoietic stem cells.  
Results 
Preliminary results have suggested that bacterial NDK proteins may follow a similar 
pattern to increase the survival of haemopoietic stem cells, as the human NM23-H1 
protein, however further work is needed to confirm such findings. The NDK mutants 
have shown to have a disrupted biology which leads to an altered expression in NDK. 
The Mutant 3, a disruption in the KPN loop, has shown a disruption in the structure of 
NDK. 
Conclusion 
The results suggest that bacterial NDK proteins could play a role in promoting the 
survival of leukaemic stem cells. This would impact patient care and treatment as well 
as requiring ongoing medical research into bacterial NDK proteins; and their 
interactions with leukaemic stem cells. The increased risk of neutropenic infections in 
patients undergoing chemotherapy could have a greater link to leukaemia than first 
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1.1 NDK Superfamily 
Nucleoside Diphosphate Kinases (NDKs) are a superfamily of proteins which are 
involved in the synthesis of nucleoside triphosphates (NTP), where a gamma-
phosphate is transferred from one NTP to NDP to produce new NTPs and NDPs. i.e. 
GTP+ADP        GDP+ATP, this maintains a balanced nucleotide pool within the cell 
(Sikarwar, et al., 2013)  (Schaertl, et al., 1999). 
 Extensive research has shown that the nucleoside diphosphate kinase proteins are 
highly conserved within eukaryotes, prokaryotes and archaea, all of which contain 
nucleoside disphosphate kinase (NDK) activity (Bilitou, et al., 2009). These proteins 
were first discovered by (Berg & Joklik, 1953) in yeast, and by (Krebs & Hems, 1953) in 
breast muscle of pigeon.  
For the purpose of this thesis, the focus will be on Human non-metastatic clone 23 
(NM23), and bacterial NDK. Human NM23, named because of its ability to function as a 
tumour suppressor in a number of solid tumours such as breast and ovarian cancers 
(Almgren, et al., 2004) play an identical role to bacterial NDK in maintaining nucleotide 
pools within the cell  (Chakrabarty, 1998). 
1.2 NDK Activity 
NDK plays a role in all cells, their primary role is to maintain NTP and (deoxy 
derivatives) dNTP pools, which are used in the synthesis of RNA and DNA. 
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(Chakrabarty, 1998) NDK provide nucleoside triphosphates for several metabolic 
processes, for example – dNTPs for nucleic acid synthesis, cytidine triphosphates (CTP) 
for the synthesis of lipids, uridine triphosphates (UTP) for polysaccharide synthesis, 
and guanosine triphosphates (GTP) for the elongation of proteins, signal transduction 
as well as polymerisation of microtubules (Tonoli, et al., 2009). 
 1.2.1 Role in Bacteria 
Bacterial NDK proteins are multifunctional housekeeping enzyme and use the 
reversible transfer of a gamma phosphate from an NTP to NDP for the essential 
generation of specific NTPs or dNTPs. The dNTPs are then used as precursor for the 
synthesis of RNA and DNA. (Ray & Matthews, 1992)  Escherichia coli NDK protein can 
interact with several proteins that are involved in DNA synthesis.  Research has shown 
that the NDK from Escherichia coli interacts with the uracil DNA glucosylase, increasing 
Ung catalytic activity. It also interacts with T4 bacteriophage encoded proteins during 
infection (Nordman & Wright, 2011). 
Bacterial NDK also play an important role in bacterial growth and cell division. The 
nucleoside triphosphate, GTP is particularly important in cellular macromolecule 
production and signalling transductions within bacteria (Chakrabarty, 1998). 
Sequencing of the NDK gene of Mycobacterium tuberculosis has shown that the NDK 
protein has a secondary function to nucleoside disphosphate kinase activity. It has 
shown to cleave single stranded DNA in the human c-myc promoter, (Kumar, et al., 
2005) and it also acts as a GTPase activating protein (Chopra, et al., 2004). 
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The NDK protein had always been considered an important enzyme for cell growth and 
division in prokaryotic organisms, however it was found that enzymes such as Pk, 
adenylate kinase and polyphosphate kinase all contain nucleoside diphosphate kinase 
activity, thus making NDK non vital in bacterial such as E. coli and P. aeruginosa (Lu, et 
al., 1996) (Sundin, et al., 1996) (Munoz-Dorado, et al., 1990). However if any of these 
enzymes are restricted then cellular growth and division become dependent on the 
nucleoside diphosphate kinase activity of NDK.  
1.2.2 Pathogenicity and NDK 
Pathogenesis of bacteria is a complicated process, which is dependent on high energy 
levels. The bacterium is required to successfully infect and proliferate within the host, 
as well as produce virulence factors. To be able to successfully carry out these 
processes, the bacterium requires the maintenance of a good energy source.  NDK 
proteins play an important role in maintaining this vital source (Chakrabarty, 1998). 
The bacterium can also obtain Adenosine triphosphate (ATP) from its host at the site 
of inflammation, which leads to cell death. (Hussain, et al., 2011) It has been suggested 
that bacterial NDK can help the cell utilise this eATP to favour their survival (Chopra, et 
al., 2003).  
NDKs have been shown to have a secretory function (Zaborina, et al., 1999) which 
plays an important role in the survival of pathogenic organisms within the host 
(Hussain, et al., 2011). This secretory function has also been suggested to play a role in 
apoptosis of macrophages (Zaborina, et al., 1999). 
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1.2.3 Role in Humans 
NM23, like the bacterial NDK is a housekeeping enzyme that plays a role in the 
transactivation on c-myc, and aids in the regulation of endocytosis. It also plays a role 
as a tumour suppressor; this is discussed in more detail in chapter 1.4 (Lee, et al., 
2009). NDK also plays a role in the differentiation of cells and protein synthesis 
(Chakrabarty, 1998). However the cellular mechanism which regulates NM23 is not 
clearly defined (Lee, et al., 2009). 
1.3 Protein Structure  
Bacterial NDK proteins are known to form homohexameric or homotetrameric 
structures (Arai, et al., 2012). Most NDK proteins are known to form a hexameric 
quaternary structure; but a few prokaryotic NDKs are tetrameric such as E. coli NDK. 
 Regardless of their quaternary structure all NDK proteins share a common dimer unit 
and the structures surrounding the active histidine site are identical in all NDKs. Apart 
from c-terminal residues found in the hexamer and not the tetrameric structure the 
nucleoside binding sites are fully conserved (Janin, et al., 2000). Research suggests that 
this assembly of subunits in a tetrameric NDK differ from hexameric NDK and also 
alters the structure of the protein (Giartosia, et al., 1996). Hexameric NDK constitutes 
3 dimers; whereas the tetramer constitutes only 2 dimers, this occurs by interactions 




















Figure 1 Ribbon Diagram of S. aureus  (Srivastava, et al., 2011) 
This image shows the hexameric structure of the bacteria S. aureus consisting of 3 

















Figure 2 Ribbon Diagram of E. coli (L.Moynié, et al., 2007) 
This image shows the tetrameric structure of E. coli consisting of 2 dimers.  
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The NDK kinase sequence is 60% homologous amongst eukaryotes and 45% 
homologous between eukaryotes and prokaryotes representing a very high degree of 
conservation (Georgescauld, et al., 2013). 
Human NM23 has at least 10 isotypes, H1-H10 (Lilly, et al., 2011), -H1 to -H4 are 
considered to play a major role in cell development.  An 88% similarity between the 
amino acid sequences of NM23-H1 and NM23-H2 was also found (Lacombe, et al., 
2000). The high similarity between NM23 H1 and H2, allow the two isotypes to fuse 
together forming a hybrid (Milon, et al., 1997). This hybrid could be useful in the 
tumour suppressor role of NM23, because in many cancers the levels of NM23-H1 and 
NM23-H2 together are found to be elevated (Konishi, et al., 1993) (Godfried, et al., 







































Figure 3 Ribbon Diagram of the hexameric structure of NM23 (Han, et al., 2010) 
Both images show a hexameric structure of NM23, in different rotations.  Both images 





1.3.1 Conserved Protein Domains of NDK 
The NDK protein consists of several conserved protein domains. These domains play 
roles in the structure and functions of the NDK protein (Georgescauld, et al., 2013) 
(Tepper, et al., 1994). Current research has suggested that the c-terminal tail found in 
hexameric NDK structure plays a crucial role in the stability in its hexameric structure. 
It is also important in full enzymatic activity of the NDK protein. Breaking the salt 
bridges between Arg80 and Asp 93 shows a decrease in the thermal stability of the 
NDK (Georgescauld, et al., 2013). 
Mutations in several conserved domains of M. tuberculosis have shown changes in the 
function and structural stability of the protein. A mutation in amino residues, Lys16 
Arg109 Asn119 have shown to interrupt sub-unit interactions thus decreasing the 
stability of the protein. The following amino acid residues Lys16, Tyr56, Arg92, Thr98, 
Arg109 Asn119, Ser124, Glu133 have shown to decrease NDK activity and binding, and have 
be found to be conserved within all NDK proteins (Georgescauld, et al., 2013). The Kpn 
loop, named after the mutation ‘killer of prune’ in Drosophila, is thought to play a role 


































Figure 4 Sequence Alignments of NDK (Georgescauld, et al., 2013) 
Figure 4 shows the sequence alignments of NDK of whose structures have been solved. 
Indicated in red are the conserved domains that span the whole NDK family. Active site 
residues are represented with a blue star. The important salt bridges are indicated by 
triangles on Arg80 and Asp93. Marked with a yellow box are human NM23 and E. coli 




1.4 NDKs association with Cancer 
1.4.1 Tumour Suppressor Function 
The NM23 gene and its role as metastatic suppressor was first noted in 1988 (Steeg, et 
al., 1988). In 1989 this gene was isolated from mouse melanoma cells by Rosengard 
(Rosengard, et al., 1989). A negative relationship between metastasis and gene 
expression was noted, and the gene named non metastatic clone 23. In 2000, this 
same pattern was noted in human breast carcinoma cell lines and human melanomas, 
suggesting NM23 plays a metastatic inhibitory role within these cancers (Hartsough & 
Steeg, 2000).  
Research on the NM23 human NDK protein, is quite conflicting, (Postel, 2003). In 
certain cancers such as aggressive neuroblastomas or colorectal cancers, NM23-H1 
and H2 RNA levels are in fact elevated. Because mutations in the NM23 gene are quite 
rare in cancers, it is thought that NM23 and its isotypes might become deregulated 
through expression at an RNA level rather than being activated through mutations. 
This would explain how an over or under expression of NM23 could be oncogenic. 
 The metastatic suppression quality of NM23-H1 has been studied in great depth by 
many researchers. In 1991, (Leone, et al., 1991) showed that metastatic k-1735 TK 
murine melanoma clones expressing NM23-H1 showed a decreased development in 
tumours. This metastatic suppression caused by NM23-H1 was also shown by many 
other researchers in; colorectal cancers, (Martinez, et al., 1995), in breast carcinomas 
(Howlett, et al., 1994) and in bladder cancers (Chow, et al., 2000). 
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In a study carried out by (Scambia, et al., 1996) a direct link between the associations 
of NM23-H1 and NM23-H2 levels were found, indicating that both proteins interact 
with each other to manage the metastatic suppression mechanism. In prostate 
carcinoma’s levels of NM23-H1 and NM23-H2 were assessed; and all cases showed an 
increased level of both NM23-H1 and NM23-H2 expression (Konish, et al., 1993). In 
current research; work is being done to determine whether NM23-H1 can be over 
expressed in tumours to decrease its metastatic potential in patients (Junghee Lim, 
2011) (Marshall, et al., 2010). 
1.4.2 NM23 and haematological malignancies  
Whereas in solid tumours, expression of NM23-H1 acts as a metastatic suppressor; in 
haematological malignancies, this does not appear to be the case. In normal 
haemopoiesis, progenitor cells express a high level of NM23-H1 and –H2, however as 
these cells mature, the levels of NM23-H1 and –H2 decrease (Willems, et al., 1998).  In 
fact the more recent research suggests that the NM23-H1 protein can act to promote 
the survival of haematological cancer cells. A study by (Lilly, et al., 2011) showed how 
NM23-H1 indirectly promoted the survival of acute myeloid blast cells. This was shown 
by the over expression of NM23-H1 in cell survival assays containing CD11b +ve cells. 
In other studies NM23-H1 levels seem to be increased in acute haematological 
malignancies, but not in chronic haematological malignancies (Yokoyama, et al., 1996) 
(Yokoyama, et al., 1998). While NM23 clearly has an important and diverse role in 





1.5.1 Haemopoietic System  
During the first few weeks of development, the embryonic yolk sac is where the initial 
haemopoietic system resides.  It consists of mainly nucleated erythroid cells, and feeds 
the embryonic tissues with oxygen. However as the embryo grows, a more 
multifaceted system takes over, which reside through adult life. This haemopoietic 
system consists of all blood cells, including erythrocytes, myeloid and lymphoid cells 
(kennedy, et al., 1997). These cells originate from multipotent haemopoietic stem cells 
(HSCs) and are initially seen in the aorta-gonads-mesonephros (AGM) region, which is 
part of the embryonic mesoderm. These haemopoietic cells also termed 
haemangioblasts concentrate in the liver, spleen and bone marrow (Taylor, et al., 
2010). After 6 weeks gestation the liver and spleen become the vital haemopoietic 
organs, until about 6/7months into fetal life, where the bone marrow becomes the 
most important site. During childhood and adult life the bone marrow is the most 
important site in which haemopoietic stem cells are produced. Developing cells inhabit 
the region outside the bone marrow sinus, and once they have reached maturity are 
released into the sinus spaces and microcirculation and then into the general 
circulation (Hoffbrand, et al., 2006) (Lilly, et al., 2011). 
1.5.2 Haemopoietic stem cells 
Haemopoietic stem cells (HSCs) are multipotent stem cells, which differentiate into the 
mature blood cells; erythrocytes, megakaryocytes and all lymphoid (T cells, B cells and 
NK cells) and myeloid cells (monocytes, macrophages, neutrophils, basophils, 
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eosinophils, dendritic cells).  They have the ability to self renew and undergo apoptosis 
if cells become damaged and are important in maintaining a constant haemopoietic 
system throughout life (Hoffbrand, et al., 2006). 
1.5.3 Haemopoietic stem cell niche 
The identification and characterisation of HSCs was initially carried out in mice. It was 
found that when HSCs where taken out of the bone marrow and its microenvironment, 
they lost their ability to self renew. This indicates that HSCs are dependent on the 
communication between themselves and other cells in their microenvironment or 
‘niche’ to maintain the HSC system. This initial ‘niche’ theory was developed by 
(Schofield, 1978).  The discovery of the stem cell niche in the 1970’s promoted further 
research to identify and understand the different components that make up this niche. 
Currently there is a debate to whether 2 HSC niches actually exist; endosteal and 
vascular niche (Lilly, et al., 2011). 









Figure 5 Haematopoietic Stem Cell and Lineage specific markers ( R&D Tools for Cell 
Biology Research, n.d.) 
Figure 5 shows the ladder of haemopoietic stem cell differentiation and the stem cell 






Leukaemia is a cancer of blood and/or bone marrow, and is characteristic of an 
increased proliferation of immature white blood cells.  Leukaemias are classified as 
acute and chronic. For the purpose of this research project, the concentration will be 
on acute leukaemias. Acute leukaemias are characterised by the rapid proliferation 
and accumulation of immature leucocytes in the bone marrow, which replace normal 
cells. Acute leukaemias are subdividing into lymphoid and myeloid, depending on 
which lineage of progenitor cells are affected. Acute lymphoid leukaemia (ALL) 
involved the lymphoid lineage and immature proliferation of lymphocytes. Acute 
myeloid leukaemia (AML) involves the myeloid lineage and immature proliferation of 
neutrophils, monocytes, eosinophils, basophils and megakaryocytes (BMJ, 1997). 
1.6.1 Leukaemic stem cells 
Morpholically the determination of ALL or AML are easy to characterise, as they are 
derived from different lineages. However the characterisation of ALL or AML blast cells 
is dependent on antigen expression (Dick, 2005). AML-stem cells express CD34 and 
CD38 along with a variety of myeloid antigen markers, including CD33, CD13, CD17 and 
CD123. (Horton & Huntly, 2012) ALL-stem cells express CD34, and antigen expression 
markers for T cells including CD7, CD4 CD5 and CD8 and antigen expression markers 
for B cells, CD19 and CD22 (Bachir, et al., 2009). 
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1.7 Neutropenic Infections 
Leukaemia patients are prone to developing infections, due to the depletion in 
immune cells, due to the intensive chemotherapy treatment, and the lack of normal 
maturation of haemopoietic progenitor cells. In an article by (Chandran, et al., 2012) it 
is pointed out that even in today’s clinical advances, infection remains a disastrous 
complication to leukaemic patients, often leading to death. Advances such as targeted 
therapies and the use of antibiotic therapies have shown a decline in neutropenic 
infections; however “infections in leukaemia remain a therapeutic challenge” 
(Chandran, et al., 2012). 
The most common bacterial infections in leukaemia tend to be by gram negative 
bacteria, this include Escherichia coli and Klebsiella pneumoniae, however some gram 
positive bacteria are also high in causing infection in leukaemia patients such as 
streptococci and staphylococci bacteria.  In this study, Escherichia coli, Klebsiella 
pneumoniae, Staphylococcus aureus and Streptococcus pneumoniae NDK proteins are 
investigated, due to its high infectious consequences to leukaemic patients (Sung, et 
al., 2007). 
 1.7.1 Escherichia coli 
Escherichia coli (E. coli) are an Enterobacteriaceae that is part of the normal flora in the 
intestines of humans and animals.  This Gram negative rod is one of the most diverse 
bacterial species with several pathogenic strains known to cause ill health. E. coli can 
grow in a range of conditions.  
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Wild type E. coli requires no additional growth factors, and can happily grow in media 
containing just glucose as a carbon source. It has the ability to convert glucose into all 
the vital macromolecules required to make up the cell and is very responsive to 
changes in environmental conditions; for example chemicals, pH or temperature. It has 
the ability to switch ‘on’ and ‘off’ certain functions, for example enzyme production for 
the synthesis of metabolites, this will only  be produced if the metabolites are available 
in their habitat, thus using energy for processes of necessity at any given time 
(Madigan, et al., 2003) (Murray, et al., 2005). 
 E. coli is a major pathogen able to cause infection of the urinary and GI tract as well as 
being a leading cause of bacteremia.  
1.7.2 Staphylococcus aureus 
Staphylococci are Gram positive spherical bacteria, and part of the normal flora of skin 
and nasal cavity.  There are over 20 species of staphylococcus bacteria, however only 2 
are major human pathogens, Staphylococcus aureus and Staphylococcus epidermidis.  
S.aureus localise within the nasal passage, oral cavity, gastrointestinal tract (Franklin & 
Lowy, 1998) (Murray, et al., 2005) (Madigan, et al., 2003). 
S.aureus can grow in a range of conditions and are a major cause of wound and 
bloodstream infections. S. aureus is a versatile and dangerous pathogen in humans and 
hospital acquired infections are still on the increase, as well as multi drug resistance S. 
aureus, posing an increased risk to immnuodeficient patients (Patrick, et al., 2013). 
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1.7.3 Klebsiella pneumoniae  
Klebsiella pneumoniae are gram negative rod shaped bacteria along with E. coli they 
belong to the Enterobacteriaceae family. Klebsiella pneumoniae are part of the normal 
flora of the gastrointestinal tract, but are ubiquitous when it comes to their habitat 
association. In the laboratory Klebsiella pneumonie grow happily in (Lysogeny) LB 
broth at 37oC (Murray, et al., 2005). 
They are quite happy to thrive in sewage, drinking water, soil and vegetation. Klebsiella 
pneumoniae are one of the most common bacterium to cause pneumoniae infections. 
It has a mortality rate of around 50% in ICU patients due to their extracellular toxic 
capsule, which causes severe lung tissue damage. The majority of infections caused by 
Klebsiella pneumoniae occur in patients with a compromised immune system 
(Madigan, et al., 2003). 
1.7.4 Streptococcus pneumoniae 
Streptococcus pneumoniae are gram positive cocci which grow in chains. In common 
with all streptococci species they lack catalase and ferment glucose to lactic acid. 
Streptococcus pneumoniae are known to cause pneumoniae infections but it is also 
associated with bacterial meningitis. Streptococcus pneumoniae make up part of the 
normal flora in the upper respiratory tract. They grow best in 5% CO2, cultures of 
Streptococcus pneumoniae require a source of catalase to neutralise hydrogen 
peroxide produced by the bacteria, where a blood source is efficient (Madigan, et al., 
2003) (Murray, et al., 2005). 
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Streptococcus pneumoniae are prone to self destruction and contain an enzyme called 
autolysin. This enzyme has the ability to cause disintegration of the cell, this occurs 
when the bacteria hit stationary phase within their growth cycle and production of 
autolysin is induced making the growth of Streptococcus pneumoniae in the lab slightly 




2. PART A INTRODUCTION 
Part A of this research project focuses on the effects of bacterial nucleoside 
diphosphate kinase (NDK) proteins on haemopoietic stem cells, derived from bone 
marrow and leukaemic samples.  
2.1 Previous Studies 
A study by Andrew J Lilly on the interactions between NM23-H1 and haemopoietic 
stem cells have shown that NM23 actually cause increased survival and proliferation of 
stem cells from bone marrow and umbilical cord bloods. In his PhD titled ‘the 
significance of extracellular NM23-H1 protein in acute myeloid leukaemia and its role 
in regulating haemopoietic stem cell behaviour’ he investigated the survival of 
umbilical cord blood stem cells, bone marrow stem cells treated with over expressed 
NM23-H1 protein. Importantly; he also investigated the affects of NM23-H1 protein on 
acute myeloblastic leukemic cells. A study by (Lilly, et al., 2011) shows how NM23-H1 
can indirectly promote the survival and proliferation of acute myeloid Leukaemias, 
where it is stated that NM23-H1 has been found to act as an ‘AML cell survival factor’ 
The study incorporates investigations into the binding mechanisms of AML to NM23-
H1, which was found to be through more mature CD11b+ve cells, and not directly to 




2.2 Aims of the project 
Considering the previous work on NM23-H1, and the similarity in structure and 
function of bacterial NDK bacterial proteins to human NM23-H1 proteins and the high 
infection rate of leukaemic patients; the survival of umbilical cord stem cells and 
leukaemic cells, in the presence of bacterial NDK proteins from Escherichia coli, 
Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus pneumoniae will be 
investigated.  The over expression of bacterial NDK protein, and human NM23-H1 and 
elution buffer control in primary cell cultures of umbilical cord stem cells and 
leukaemic cells  will be investigated to monitor and analyse the survival of stem cells.  
I hypothesise that bacterial NDK proteins will promote the survival and proliferation 






3. PART A METHODS AND MATERIALS 
3.1 The production of his-tagged recombinant NDK protein 
3.1.1 Polymerase chain reaction 
To amplify Bacterial NDK DNA for cloning, from Escherichia coli, Klebsiella pneumoniae, 
Staphylococcus aureus and Streptococcus pneumoniae.  Each 1xPCR Mix (thermo 
scientific, (50uL) contains;  34uL dH20, 5uL (x10) Accuzyme Buffer, 1uL (50mM) MgCl2, 
5uL (10mM) dNTPs, 2uL NDK forward primer, 2uL NDK reverse primer, 2uL taq 
polymerase and 1uL NDK DNA.  
Primer Sequences: 
E. coli/K.pneu Forward   5’ GTAGCATATGGCTATTGAACGTACTTTTTCCATC 3’ 
E. coli Reverse    5’ GTAGGGATCCTTATTAACGGGTGCGCGCGGGCACAC 3’ 
K.pneu Reverse   5’ GTAGGGATCCGATTAGCGAGTGCGCGGGCAAACC3’ 
S.aur Forward   5’ GTAGCATATGGAACGTACATTTTTAATGATTAAAC 3’ 
S.aur reverse   5’ GTAGGGATCCATTTTATTCATATAACCATGCATC 3’ 
S. pneu forward    5’ GTAGCATATGGAACAAACATTCTTTATCATCAAA 3’ 
S. pneu reverse   5’ GTAGGGATCCCTCTTAAAACCAAAGAGCAATTTC 3 
 
2 controls containing no NDK DNA were amplified. Control 1 containing forward and 
reverse primers for E. coli and K. pneu and Control 2 containing forward and reverse 






94oC  --> 5 minutes (denaturation) 
94 oC  -->  15 seconds (denaturation) 
60 oC  -->  15 seconds (primer annealing)  x 40 Cycles.  
72 oC  -->  45 seconds (primer extension) 
72 oC  -->  5minutes (final extension) 
8 oC  --> hold, over night.  
 
To check the quality and quantity of amplified DNA product, after amplification 5uL of 
PCR NDK product was mixed with 2uL of 4x gel loading buffer (see appendix for buffer 
recipe) and run on a 1% agarose mini gel containing 5uL/100mL ethidum bromide (see 
appendix for gel recipe) and electrophoresed in running buffer (see appendix for 
buffer recipe) at 70V for 45 minutes. 5uL hyperladderTM IV (Bioline) added into first 
well, and 5ul sample added to consecutive wells.  The product was observed under UV 
light.  
3.1.2 Agarose gel electrophoresis and DNA purification 
Amplified NDK products run on 1% agarose gel containing 5uL/100mL ethidium 
bromide. (see appendix for gel and buffer recipe) 50uL of PCR NDK product was mixed 
with 12uL of 4x gel loading buffer (Bioline) and electrophoresed in running buffer at 
100V for 45 minutes.  5uL of HyperladderTM IV (Bioline) added into first well and 40uL 




After completed gel run, NDK bands (500bp) were extracted under UV light and 
weighed. NDK DNA bands were purified using QIA Quick PCR purification kit (Qiagen) 
according to manufacturer’s instructions. 
3.1.3 Cloning bacterial NDK into pET15b Plasmids 
pET15b expression vector (Novagen, Merck Chemicals)  
Figure 6 pET15b Expression Vector 
 
Restriction Enzyme Digest: 
Bacterial NDK PCR products and pET15b plasmid were digested with Nde1 and BamH1 
restriction enzymes, in 10x R.E buffer (thermo scientific) overnight at 37oC. 1x 
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Restriction enzyme digest mix contains 31uL dH20, 5uL 10x RE buffer, 2uL Nde1 and 
2uL BamH1-HF restriction enzyme, and 10uL NDK DNA.  
To purify the digested pET15b vector, sample (50uL) was mixed with 12uL 4xGLB and 
run on a 1% agarose gel, in running buffer at 100V for 45 minutes. 5uL of 
hyperladderTM IV (Bioline) was added to the first wells and 40uL samples added to 
consecutive wells. Bands at 5Kbp were extracted and purified using QIA Quick Spin Gel 
Extraction Kit (Qiagen) according to manufacturer’s instructions.  
45uL of digested NDK PCR product was purified using QIA Quick PCR purification kit 
(Qiagen) according to manufacturer’s instructions. Purified digested NDK are run on a 
1% agarose gel, at 100V for 45 minutes. 
Digested NDK DNA is sent for sequencing to check for mutations. 2uL NDK DNA mixed 
with 1uL 5uM Primers (forward and reverse primers specific to NDK) and 7uL dH20.  
Sent to genomics for sequencing. 
pET15b and NDK Ligation Reaction: 
T4 DNA ligase is used to ligate the digested bacterial NDK protein coding region into 
the multiple cloning site of pET15b vector. 1x ligate mix contained; 2uL 10x ligase 
buffer (thermo scientific) 5uL Vector DNA, 10uL NDK DNA, 2uL T4 DNA Ligase and 1uL 





Competent Bacterial Transformation: 
Ligated NDK and pET15b vector are transformed into DH5 alpha competent E. coli 
cells, which have high transformation efficiency. Competent E. coli cells are thawed on 
wet ice. 3uL ligated NDK are added into 50uL competent E. coli cells, a control, 2uL 
vector only is added into competent E. coli cells, mixed well and incubated on ice for 
30 minutes. Cells were heat shocked in a 42oC water bath for 45 seconds and then 
back on ice for 1 minute. 950uL of SOC media (Qiagen) is added and rocked at 37oC for 
1 hour. Centrifuge at 15,000RPM for 5 minutes, discard 800uL supernatant and 
resuspend pellet in remaining fluid. 100uL transformation suspension are plated on 
ampicillin resistant agar plates under aseptic conditions and incubated over night at 
37oC.  
Colony PCR: 
To screen colonies for NDK insert, 5 colonies were chosen from each agar plate. 10uL 
dH20 was mixed with each colony. 2 controls, Vector only and Negative control for 
each bacterial NDK was mixed with 10uL dH20. Bacteria lysed at 95
oC for 10 minutes. 
1x PCR mix contains, 3.4uL dH20, 2uL 10x accuzyme buffer (0.6uL 50mM MgCl2, 1uL 
10mM dNTPs, 1uL Redtaq DNA polymerase, 1uL 10uM T7 polymerase primer 





94oC  --> 5 minutes (denaturation) 
94 oC  --> 20 seconds (denaturation) 
55 oC  -->  20 seconds (primer annealing)  x 40 Cycles.  
72 oC  -->  45 seconds (primer extension) 
72 oC  -->  5minutes (final extension) 
8 oC  --> hold, over night.  
5uL GLB was added to PCR product, and run on a 1% agarose gel, run at 100V for 
45minutes.  
Miniprep DNA Purification, (Qiagen) 
Colonies were selected from colony PCR, and an overnight culture was set up in 2mL L-
broth containing 100uL/mL ampicillin per bacterial NDK, over night in a shaker at 37oC. 
Plasmid DNA was purified using a DNA miniprep purification kit, following 
manufacturer’s instructions.  
Mini prep plasmid DNA was sent for sequencing, 1x reaction mix contained; 7uL dH20, 
2uL plasmid and 1uL either T7 promoter primer, or NDK Reverse primer.  
Plasmid DNA is also checked by restriction enzyme digest. 1x digest mix contains; 
15.5uL dH20, 5uL plasmid DNA, 2.5uL 10x Buffer 4, 1uL Nde1 and 1uL Bam-H1-HF. 
Incubated at 37oC for 90 minutes. 5uL digested samples were mixed with 5uL GLB, and 
20uL dH20 and 5uL hyperladder
TM I (Bioline) added into first well, 15uL of digested and 
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un digested plasmid DNA added onto consecutive wells and run on a 1% agarose gel, 
run at 100V for 45minutes. 
3.1.4 Transformation into BL21 (DE3) protein expression cells 
Using the sequence DNA plasmid digest results 1 colony of NDK from each bacterial 
species is selected. Each NDK colony is cultured over night in 2mL Lysogeny-broth (LB) 
media plus 100uL/mL ampicillin in a shaker at 37oC. 
A LB agar plate is streaked with each NDK, under aseptic conditions.  
1.5mL overnight cultures are purified using mini prep DNA purification Kit, (Qiagen) 
under manufacturer’s instructions.  
Purified pET15b-NDK construct is transformed into BL23 (DE3) expression E. coli cells 
(Novagen) according to manufacturer’s instructions.  BL21 (DE3) are high level 
expression E. coli bacterial cells, which induces the T7 polymerase gene using 
Isopropyl-1-thio-β-Dgalactopyranoside (IPTG) (Sigma-Aldrich).  BL21 (DE3) cells are 
thawed on wet ice. 2uL of pET15b-NDK plasmid construct was added to 50uL of 
competent cells. These were incubated on ice for 30 minutes. Cells were heat shocked 
at 42oC for 45 seconds, and then incubated on ice for a further 2 minutes. 950uL of L-
broth added to each cell suspension. Shake at 200RPM for 1 hour at 37oC. Cell 
suspension is centrifuged at 15,000RPM for 5 minutes, 800uL supernatant is discarded 
and pellet resuspended in remaining fluid. 100uL transformation suspension is plated 
on ampicillin resistant agar plates under aseptic conditions, (see appendix for buffer 
recipe) and incubated over night at 37oC. 
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3 colonies were chosen and a colony PCR was done to check inserted NDK gene. 
Colony PCR product was run on agarose gel.  
Glycerol stocks were made by adding 200uL of 100% glycerol to 800uL of BL21 (DE3) 
cells, and these are stored at -20oC, until used. 
3.1.5 Growth Kinetics – optimisation of IPTG induction for r-NDK 
expression 
From the glycerol stock, 7.5mL L-Broth was inoculated from each pET15b-NDK BL21 
(DE3) cells and incubated overnight at 37oC in a shaking incubator.  The next day, the 
overnight cultures are taken down to microbiology, where growth kinetic analysis was 
done. 20uL of bacterial culture of each bacterial NDK was added to 10mL L-broth 
media. 195uL of diluted culture was added to a 96 well plate, 5uL of 40mM stock IPTG 






 1 2 3 4 5 6 7 8 9 10 11 12 
A B EC SA EC SA EC SA EC SA EC SA  
B B EC SA EC SA EC SA EC SA EC SA  
C B EC SA EC SA EC SA EC SA EC SA  
D B EC SA EC SA EC SA EC SA EC SA  
E  KP SP KP SP KP SP KP SP KP SP  
F  KP SP KP SP KP SP KP SP KP SP  
G  KP SP KP SP KP SP KP SP KP SP  






Table 1 1 IPTG Induction of bacterial NDK at differing time intervals 
 
  
 IPTG added at:   
 No IPTG EC E. coli 
 0 Hours KP K.pneu 
 2 hours SA S.aur 
 5 hours SP S.pneu 
 8 hours   




pET15b-NM23-H1 BL21 (DE3) cells and BL21 (DE3) cells were used as 
control/comparable samples.  
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A B NM23 BL21 NM23 BL21 NM23 BL21 NM23 BL21 NM23 BL21  
B B NM23 BL21 NM23 BL21 NM23 BL21 NM23 BL21 NM23 BL21  
C B NM23 BL21 NM23 BL21 NM23 BL21 NM23 BL21 NM23 BL21  









Table 2 IPTG Induction of NM23-H1 and BL21 (DE3) only at differing time intervals 
 
Following the optimisation of IPTG induction, 2mL Bacterial over night cultures were 
diluted the next day in 100mL L-broth Media (1 in 50 dilution). These were incubated 
for approximately 4 hours until OD600nm had reached 0.4. (Optimum for IPTG 
induction). At time points of every hour, (up to 6 hours) and then the next day (18 
hours) 1mL of culture was centrifuged at 15,000RPM for 1 minute, supernatant 
discarded and pellet resuspended in 100uL of 1xGLB. 
Each time point sample for each pET15b-NDK construct was run on a 1.5% acrylamide 
gel. (See appendix for recipe) bacterial pellet in 1x GLB buffer is boiled for 5 minutes, 
to denature proteins. 5uL of Protein Marker is added into first well of each gel, and 
 IPTG added at: 
 No IPTG 
 0 Hours 
 2 hours 
 5 hours 
 8 hours 




50uL of bacterial sample at each time point is added to consecutive wells. Gels were 
run at 120V for 1hr 30minutes. Gels were stained in Coomassie blue stain (See 
appendix for recipe), for 2 hours and de-stained n 7% acetic acid and 5% methanol 
over night.  
3.1.6 Expression and His-tag Purification of r-NDK proteins 
pET15b-NDK BL21 (DE3) cells are cultured over night in 5mL of L-broth media with 100 
mg/ml ampicillin at 37oC at 220 RPM. The next day 2uL of culture is diluted into 100mL 
(1 in 50 dilution) of L-broth media with 100 mg/ml ampicillin, and incubated 37oC, at 
220 rpm for 4/5 hours, until OD600nm reaches 0.4. 1mmol IPTG is added, and incubated 
overnight (18 hours) at 37oC at 220 rpm.  
The next day, cultures are spun down at 15,000RMP for 10 minutes, supernatant is 
discarded, and wet pellet is weighed. Bacterial pellet was resuspended in 5mL/1g 
weight pellet of BugBusterTM (Novagen). 1uL/1mL benzonase is added to suspension, 
and is incubated at 50rpm for 1 hour to lyse bacterial cells and release NDK protein.  
His-tagged purification kit (Novagen) is used to purify the His-tagged NDK protein from 
the lysed suspension, following manufacturer’s instructions. 2mL His bind resin is 
added to chromatography column, once storage buffer has moved through the 
column, 3mL dH20 is added to the column, followed by 5mL charge buffer, and then 
3mL binding buffer. Once binding buffer has moved through the column, lysed 
bacterial suspension is added to the column. Once the bacterial suspension has moved 
through the column, 10mL binding buffer is added, and then column washed in 6mL 
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wash buffer. His-tagged protein is then eluted in 1mL fractions in elution buffer. 
Buffers are made up under manufacturer’s instructions.  
30uL of each fraction is mixed with 10uL 4xGLB, samples are boiled for 5 minutes, and 
run on a 1.5% acrylamide gel. 5uL protein marker (Bioline) is loaded into first well, and 
20uL of each fraction is loaded into consecutive wells. Gels are run at 120V for 1 hour 
30 minute. Gels are stained in Coomassie blue stain for 2 hours and destained in 7% 
acetic acid and 5% methanol overnight. Protein fractions are observed for quantity and 
purity of protein present. The concentration of protein in each fraction was 
determined. Protein concentration was further determined using western blot 
analysis.  
3.1.7 Protein Determination  
Fractions with most protein are pooled together. 2uL of 0, 0.625, 1.25, 2.5,5 and 10ug 
protein standards are added to a 96 well plate. 2uL of NDK protein are added to a 96 
well plate. 20uL of Reagent S (Thermo scientific) is added per 1mL of Reagent A 
(Thermo scientific). 25uL of Reagent A+S is added to each well. 200uL of Reagent B 
(Thermo scientific) is added to each well and incubated at room temperature for 15 
minutes. Plate is read on a plate reader, measuring OD645nm. Protein concentration is 
determined in excel. Standard curve is plotted and equation taken from trend line, to 
determine concentration of protein. Proteins are then diluted to 200ug/mL and stored 
in the cold room until used.  
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3.2 NDK Protein Analysis 
3.2.1 Western blot analysis 
15% gels are prepared, consisting of an 8mL resolving layer and a 2mL stacking layer, 
made to 1.5mm thickness. The 1.5mm plate and small glass plate are held together in 
a casting frame and stand. The resolving layer (see appendix for recipe) is poured into 
the plate, and 600uL of dh20 is added on top to ensure a straight surface. Once the gel 
has set (~10minutes) the stacking layer is added, (see appendix for recipe) and 1.5mm 
comb inserted carefully to ensure no air bubbles. Protein samples are boiled for 5 
minutes to denature protein bonds and unfolded proteins and are run on the gel at 
120V. 
After gel has run, protein gels are transferred onto a PVDF membrane, using a semi-
dry transfer tank. PVDF membrane is rehydrated with methanol for 3 seconds, and 
then washed in dH20, before transferred into transfer buffer (see appendix for recipe). 
12x 3mm filter paper is also soaked in transfer buffer. 6 pieces of filter papers are 
layered onto the transfer tank, then the PVDF membrane is added, on top of which the 
protein gel is layered, and lastly another 6 pieces of filter paper. This is transferred for 
1 hour at 25V. 
 
After the transfer the membrane is blocked in 5% milk for 1 hour on the rocker at 
20RPM. Membranes are then washed in TBS-T (see appendix for recipe) x3 for 5 
minutes. Membranes are then probed with primary antibody; (Santa cruz) NM23-H1 
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antibody is added 1:1,000 dilution into 5% milk solution and incubated overnight in the 
cold room on the rocker at 20RPM. Membranes are washed x3 in TBS-T and probed 
with secondary anti-rabbit, diluted 1:1,000 in 5% milk. Membranes were incubated for 
2 hours on rocker at 20RPM. Membranes were washed x3 in TBS-T and then 1.5mL  
 
Supersignal West Pico Chemiluminescent substrate (Pearce), Stable peroxide solution 
and Luminol/Enhancer solution were added in equal parts were added onto the 
membranes, for 5 minutes. Excess solution was drained and membranes were 
wrapped in cling film. Membranes were placed into a film cassette and photographic 
film exposed to the membrane and developed in the dark room.  
3.2.2 Coomassie blue staining 
This technique can be used to determine purity of protein present on a gel. SDS page 
protein gel is stained in Coomassie blue dye (see appendix for recipe) for 
approximately 5 hours, until gels are sufficiently stained blue. They are then de-stained 
in 7% acetic acid and 5% methanol over night. Gels are then viewed under UV light.  
3.2.3 NDK cross reactivity with NM23 Antibody 
12ul of each NDK protein is mixed with 4uL 4xGLB, and run onto 3 1.5% acrylamide gel; 
4uL of protein is added into wells. Each gel consists of NM23, E. coli, K. pneumonie, S. 
aureus and S .pneumonie protein and run at 120V for 1 hour and 30 minutes. Following 
the western blot protocol, 3 different NM23-H1 antibodies are used to determine the 
cross reactivity with NDK protein.  
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3.3 Primary sample purification and cell culture 
Umbilical cord blood (CB) samples were provided by the Tissue Bank, University of 
Birmingham and Leukaemic samples are provided by School of Dental and Medical 
sciences, University of Birmingham. The umbilical cord blood samples and leukaemic 
sample are handled under the approval by the ethical committee. 
 





3.3.1 Ficoll-paqueTM Purification 
Umbilical cord blood samples were diluted 1 in 2, into RPMI 1640 media (Sigma 
Aldrich), plus 5mL of Penicillin Streptomycin. 12mL Ficoll-paqueTM PLUS 
(G.E.Healthcare,  UK)  is added into 50mL tubes and 30mL of umbilical cord blood is 
gently layered on top. Samples are centrifuged at 1340RPM for 40 minutes with no 
break. Supernatant is pipetted off, and mononuclear layer is retrieved carefully and 
added into fresh 50mL tubes.   
 
Figure 8 Ficoll-paqueTM Purification 
 
Mononuclear cells are collected carefully from the separated Ficoll tube. Mononuclear 
cells are washed 1 in 3 with RPMI media, (Sigma Aldrich) and centrifuged at 374g for 
10 minutes. Supernatant is discarded and resuspended in 30mL of RPMI Media (Sigma 
Aldrich) and centrifuged at 249g for a further 10 minutes. This is repeated. The 
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supernatant discarded and cells are resuspended in 10mL RPMI Media (Sigma Aldrich) 
with Insulin-transferrin-sodium (ITS+). Leukocytes are counted using haemocytometer.  
3.3.2 CD34+ve cell sorting  
The mononuclear cells are sorted for CD34+ve using CD34 Microbead kit (Miltenyi 
Biotec UK) following manufacturer’s instructions. Cells are centrifuged in RPMI Media 
(Sigma Aldrich) at 300g for 10 minutes, and resuspend in 400uL/108 cells in cold (4oC) 
Magnetic Activated Cell (MACs) buffer. (see appendix for recipe). 100uL/108 cells of 
FcR block is added, and 100uL/108 cells CD34 Hapten-antibody are added to cell 
suspension in MACs buffer. Mix well and incubate at 4oC for 15 minutes. Cells are 
washed in 5mL/x108 cells MACs buffer, centrifuged at 300g for 10 minutes. MACs 
buffer is discarded and cells are resuspended in 400uL/108 cells of MACs buffer. 100uL 
per 108 cells of anti-hapten microbeads are added to cell suspension, and centrifuged 
at 300g for 10 minutes. Cells are washed in 2mL/108 cells, MACS buffer and 
centrifuged at 300 g for 10 minutes and then resuspended in 500uL/108 MACs buffer. 
Following manufacturer’s instructions, cells are sorted using MACs columns. 
Dependant on cell number MS or LS columns are used. 
 
Column Max. No. of labelled 
cells. 
Max. No. of total 
cells. 
MS 107 2x108 
LS 108 2x109 
XS 109 2x1010 
 




Column is rinsed with MACs buffer (500 μl for MS, 3 ml for LS) cell suspension is added 
and elutes are collected into a fresh 50mL tube. Column is washed 3 times with MACS 
buffer; this is collect into the same tube. These are the CD34-ve cells. 
Column is removed from the magnet and MACs buffer added into the column, a 
plunger is used to flush through the CD34+ve cells into a fresh 50mL tube. The CD34-ve 
cells are also sorted further, using the same protocol, but to purify for CD11b+ve cells. 
CD34+ve and CD11b+ve cell suspensions are centrifuged at 300g for 10 minutes and 
resuspended in 1ml RPMI 1640 (Sigma Aldrich) plus ITS+ per 106 cells. The CD34+ve 
cells are stored in the fridge overnight.  
The purity of CD34+ve cells were analysed using Fluorescent activated cell sorting 
(FACs). 
3.3.3. CD34-ve Cell treatment  
CD34-ve/CD11b+ve cells are seeded at x106/mL. 1mL of cell suspension is added into 
each well on a 48 well plate. The seeded cells were treated with 2ug/ml of rNDK 
proteins from NM23-H1, E. coli, K. pneumonie, S. aureus and S. pneumoniae as well as 
an elution buffer (Novagen) control. These are then incubated overnight (~20hours) at 
37oC in 5% CO2 environment. 
The following day the treated CD34-ve/CD11b+ve cells are depleted of protein. 100uL 
of HIS-Select Nickel affinity Resin (Sigma Aldrich) is required per mL of cell suspension. 
1mL of conditioned media is removed for each NDK treatment. The remaining CD34-
 
 41 
ve/CD11b+ve treated cells (named sample 1) are left in the incubator for 11 days to 
study the viability of CD34-ve cells.  
3.3.4 Protein Depletion 
600uL HIS-Select nickel affinity Resin (sigma Aldrich) is removed from storage buffer, 
centrifuged at 15,000 RPM for 5 minutes, and washed in 1mL dH20, centrifuged at 
15,000RPM for 5 minutes. dH20 is discarded and resin washed in 500uL of equilibrium 
buffer, (see appendix for recipe) centrifuged at 15,000 RPM for 5 minutes. Supernatant 
is discarded and resin resuspended in 600uL of equilibrium buffer. 100uL of resin 
transferred into labelled eppendorfs for each protein, centrifuged at 15,000RPM for 5 
minutes and equilibrium buffer removed. Conditioned CD34-ve media is added to 
eppendorfs corresponding to NDK protein labels. Mix well, and rotate in the cold room 
for 30 minutes. Resin is removed by centrifugation at 15,000 RPM for 5 minutes. 
Supernatant is added into fresh eppendorfs labelled for NDK protein. 100uL of 
depleted conditioned media is mixed with 25ul 4x GLB, to run on acrylamide gel. 20uL 
of sample is inserted into each well, and run at 120V for 1 hour and 30 minutes.   
3.3.5 CD34+ve Cell treatment 
CD34+ve cells from the fridge are counted using the haemocytometer. Centrifuge at 
300g for 10 minutes and resuspend at x106/mL in rNDK protein depleted conditioned 
media. Cell suspension are added into a 96 well plate (200uL per well) and incubated 
at 37oC, 5% CO2 for 5 days.  
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3.3.6 Leukaemic cell treatment 
Leukaemia samples are washed in 3x RPMI 1640 media (Sigma Aldrich) with Pen/strep 
at 374g for 10 minutes. RPMI is discarded and cells resuspended in 15ml of RPMI and 
centrifuged at 249g for 10 minutes x2. Cells are counted using a haemocytometer, and 
resuspended in RPMI Media (Sigma Aldrich) with ITS+ and Pen/strep, at x106 cells per 
mL. Samples are added into 96 well plates, and 200uL added into each well. 2uL of 
200ug/mL protein stock are added to wells. Each protein sample added to separate 
wells, and survival of leukaemic cells are determined after 5 days incubating at 37oC in 
a 5% CO2 environment. 
3.4 Flow cytometric Analysis 
Identification of cell viability is detected using cell surface markers. Antibodies 
corresponding to primary cells of interest are incubated with cells and then analysed 
using FACs.  
Primary cells are stained for CD34+ve cells using CD34 APC antibody (miltenyl biotec, 
UK) before they are sorted. Post sorted primary cells are also stained for CD34+ve cells 
and CD34+ve cells are harvested after 5 days of treatment with NDK protein, and 
stained for CD34 surface marker. CD34-ve cells are stained for CD34, CD11b, CD19, 
CD3, CD14, CD14, and CD33 (miltenyl biotec, UK) to identify the viability of cells after 
culturing with NDK protein for 11 days.  
100uL of each protein treated cells are mixed with 5uL FcR block, and 2uL of CD34 APC 
antibody (miltenyl biotec, UK). Samples are incubated in the dark for 10 minutes, and 
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then washed in 2mL PBS and centrifuged at 2,000 RPM for 5 minutes. Supernatant is 
discarded and 200uL FACs Fix is added to stained cells. Samples are transfer into FACs 
tubes and stored in the cold room, under foil, until processed. This process is repeated 
for each NDK treated harvested cell suspension, to stain for APC isotype control 
(miltenyl biotec, UK); 2uL of CD34 APC antibody is replaced with 2uL of APC Isotype 
(miltenyl biotec, UK).  
For the identification of CD34-ve cell viability a cocktail or antibodies are made. 1st 
cocktail contains 70uL of FcR block, 30uL of CD19 APC, CD3 FITC, and CD14 PE (miltenyl 
biotec, UK). 2nd cocktail contains 70uL FcR block, 30uL of CD33 PE and CD15 FITC 
(miltenyl biotec, UK). 3rd cocktail contains 70uL FcR block, 30uL of CD11b PE and CD34 
APC (miltenyl biotec, UK). The 4th cocktail contains isotypes, 30uL of APC, PE and FITC 
and 70uL FcR block (miltenyl biotec, UK).  
700uL of CD34-ve cell suspension is harvested for each NDK treatment. These are split 
into 4 eppendorfs, 200ul into 3 eppendorfs and 100uL into the 4th eppendorf. Each 
eppendorf is marked corresponding to the cocktails. 11uL of cocktail 1 is added into 
eppendorf 1, 9uL of cocktail 2 into eppendorf 2, 9uL of cocktail 3 into eppendorf 3 and 
11uL of cocktail 4 into eppendorf 4. These are then incubated and protocol followed as 
above. 
Acute lymphoid leukemic cells are stained for CD19 and CD34 surface markers 
(miltenyl biotec, UK), and Acute myeloid leukemic cells are stained for CD33 and CD34 
surface markers (miltenyl biotec, UK), following the protocol as above.  
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Before FACs analysis, 10uL of cytocount beads (miltenyl biotec, UK) are added into 
each tube.  
3.5 Microscopic Images of CD34-ve treated cells 
Before CD34-ve cells are harvested, microscopic images are taken using a camera to 
capture the viability of cells treated with NDK proteins. After harvesting microscopic 
images are taken of Jenna Giemsa stained slides to study the morphology of treated 
and untreated cells.  
3.6 Jenna Giemsa Staining 
CD34 –ve cells are stained with Jenna Giemsa so that the morphology of the cells can 
be studied. After 11 days the CD34-ve cells treated with the NDK proteins are 
harvested. 100uL of cell suspension is added into a cytospin chamber, and centrifuged 
for 3 minutes at 500 RPM. Slides are left to air dry until the next morning.  
The next morning slides are fixed in 50uL of methanol and left to air dry until all 
methanol has evaporated. Giemsa buffer (see appendix for recipe) is diluted 1 in 25 in 
dH20 into 200mL. Jenna stain is made up 1 in 3 in Giemsa buffer into 50mL per coplin 
Jar. Jenna stain is transferred into the coplin Jar and fixed slides are inserted, and left 
to stain for 5 minutes at room temperature. Slides are washed thoroughly in dh20 until 
colour runs clear. Giemsa stain is diluted 1 in 20 in Giemsa buffer in 50mL per coplin. 
Giemsa stain is transferred into the coplin Jar, and slides are stained for 5 minutes at 
room temperature. Slides are washed thoroughly in dh20 until water runs clear. Slides 








4. PART A RESULTS 
4.1 Cloning of bacterial NDK DNA into pET15b expression vector 
Bacterial NDK DNA from Escherichia coli, Klebsiella pneumoniae, Staphylococcus 
aureus and Streptococcus pneumoniae were PCR amplified using modified primers (A), 
specific to the NDK gene. Amplified PCR products (D) were gel purified and digested 
using Nde1 and BamH1 restriction enzymes along with the pET15b-NM23-H1 plasmid 
(B), producing an empty vector (C), ready for the ligation of NDK DNA.  
The NDK DNA digestion produces blunt ends, which will ligate into the pET15b plasmid. 
Ligates of pET15b plasmid and NDK DNA were transformed into DH5 alpha competent 
E. coli cells. These were grown over night on ampicillin resistant agar plates. The 
pET15b vector contains an ampicillin resistant gene, which is used to select colonies 
which have successfully been ligated. Successfully colony growth indicates the 
bacterial NDK has been ligated into the pET1b5 plasmid, and therefore grows on an 
ampicillin resistant plate. Any bacterial containing unsuccessful ligations will not have 





Figure 10 Schematic Diagram of Bacterial NDK Cloning into pET15b Vector 
Figure (A) shows modified primers used for amplification of NDK DNA, for full primer 
sequences see appendix. (B) Shows pET15b-NM23 vector, which is digested with Nde1 
and BamH1 restriction enzymes (C). Amplified NDK DNA (D) are digested and purified 
(E), and ligated with pET15b Vector and transformed into DH5alpha cells. Colony PCR is 
performed (G) to screen bacterial colonies for NDK insert. Figure (G) shows pET15b-
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4.2 Sequence Alignments as confirmation of NDK cloning into 
pET15b plasmids  
pET15b-NDKs were sequenced, and aligned with existing NDK sequences using BLAST 
to ensure the sequences were 100% correct. These were then translated into their 
amino acid sequence, using ExPASy translate. Successful protein sequences for the 
four bacterial strains are shown below. 
pET15b Plasmid   NDK   NdeI restriction Site   BamHI Restriction Site 
Figure 11 sequence alignments of DH5alpha transformed pET15b-NDK ligates 




4.3 Optimisation of IPTG induction of NDK Proteins in BL21 
(DE3) expression cells. 
pET15b-NDK in DH5 alpha competent cells, were transformed into BL21 (DE3) protein 
expression cells. Colonies were selected, screened using colony PCR. A successful 
colony for each bacterial NDK was selected and an overnight culture grown.  
Bacterial growth kinetics was done on these cultures, to identify the optimum time for 
induction with IPTG, for the expression of protein. IPTG induces lac operon. It binds to 
the lac repressor and deactivates it, allowing transcription of NDK gene to occur. 
Optimisation of induction allows for the maximum yield of protein.  
From the results (figure 12), a time frame between 2-5 hour growth prior to induction, 
showed to have the best induction affects on BL21(DE3) cells for the  expression of  
NDK protein. Induction at 0 hours showed to increase the lag phase of the bacteria, 
and induction at 8 hours showed to create a bigger environment change during 
bacterial growth phase indicated by the dip on the graph. However despite different 
timed inductions, each bacterial growth reach a similar OD as it reaches stationary 
phase.  
It was decided for experimental purposes that prior to induction bacteria will be left to 
grow for 4 hours, before induction with 1mmol of IPTG.  
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Figure 12 Optimisation of IPTG Induction 
Figure 12 shows the induction of IPTG over 5 different time points for BL23 (DE3) NDK proteins from E. coli, K. pneu, S. aur and S. pneu. A 




4.4 Expression of r-NDK proteins in BL21 (DE3) expression cells  
BL21 (DE3) pET15b-NDK plasmids were induced at 4 hours after growth, and at every 
hour, protein expression was monitored. From the figure below (figure 13) you can 
observe that BL21 (DE3) continuously expressed protein, up to 18 hours. Results from 
BL21 (DE3) protein expression, illustrates protein expression is not inhibited, at any 
point during the time measured, and therefore BL21(DE3) bacteria can be induced and 








Figure 13 Acrylamide Gels of Protein Expression over 18 Hours 
Figure 13 shows the expression of bacterial NDK after induction with 1mmol IPTG, at 
every hour until 6 hours, and then the next day at 18 hours. Bacterial culture was 
mixed with GLB, denatured and run on the gel to observe protein quantity, using 




4.5 His-tagged Purification of r-NDK proteins in BL21 (DE3) 
expression cells  
Overnight cultures are diluted 1 in 50, left to grow for 4 hours and induced with IPTG, 
protein expression occurs over 18 hours. Bacteria are lysed and proteins expressed 
using his tag affinity chromatography. Purified fractions of protein were run on a gel, 
to determine quantity of protein within each fraction. From the results below, fraction 









Figure 14 Purified Fractions of NDK Protein 
Figure 14 shows the elution of his-tagged NDK protein through the chromatography 
column. Elution is split into 1ml fractions, where fraction 1 is first off the column and 




4.6 Western Blot Analysis of NM23 antibody cross reactivity 
with NDK proteins 
Cross reactivity of 3 NM23-H1 antibodies were determined, Santa Cruz biotech C-20, 
NME1/NDKA Cell Signalling, and Gentex NM23, using western blot analysis. The results 
below show that both the Santa Cruz and Gentex antibodies cross react with bacterial 
NDK protein. This allows us to use Gentex or Santa Cruz antibody to determine 









Figure 15 Western Blot analysis to show cross-reactivity of NM23 antibody with 
bacterial NDK Protein 
Figure 15 shows the cross reactivity of bacterial NDK proteins with 3 NM23 antibodies. 
1ug of NM23 protein and 5ug of bacterial NDK protein was added. Film was left to 





4.7 Determining Purity of CD34+ve cell sorts (Pre and post sorts 
of cord bloods) 
Umbilical cord blood samples were sorted for CD34+ve stem cells. A pre and post sort 
stain/FACs analysis was run to determine the purity of the CD34+ve sorts. The plots 
below compare side scatter with CD34 APC staining. Side scatter is an indication of the 
granulation of cell cytoplasm, and this can be used to determine cell maturity, where 
low granulation occurs in immature cells, and high granulation in more mature cells. 
CD34 is a stem cell marker, and occurs on haemopoietic progenitor cells. In the post 
sort CD34+ve APC Plot (figure 16), you can see that CD34-ve cells are also present, 
indicating that the purity of the cell sorting is not sufficient. 
Table 3 shows the percentage purity of CD34+ve cells in the sorts, which range from 
43-75%. 
Umbilical Cord Blood 
Samples 







Table 3 Percentage purity of CD34+ve cells 













Figure 16 Dot Plot to show purity of CD34+ve Post Sorted Cells 
Representation of Pre and Post sort data, of umbilical cord blood samples. FACs analysis of side scatter vs. CD34 APC, shows negative ISO 
type controls, and shows the presence of CD34+ve cells post sort and Post sort CD34-ve elute shows a nice negative population for 





4.8 His-tagged Protein Depleted conditioned media 
CD34-ve NDK protein conditioned media, were depleted before the conditioned media 
was put onto the CD34+ve cells. The depletion of bacterial NDK proteins was checked 
using western blot analysis. Due to weak cross reactivity of K. pneu, S. aur and S. pneu 
with 5ug of protein, protein depletion was checked on elution buffer control, NM23 
and E. coli. Figure 17 below indicates a successful depletion, as no NDK protein was 
observed in the wells where depleted protein samples were added. 
 
Figure 17 Western Blot Analysis of Depleted and Non Depleted NDK protein 
Figure 17 shows the depletion of NM23 and E. coli, using 1:1,000 dilution of Santa Cruz 







4.9 Bacterial NDK proteins indirectly promotes the survival of 
CD34+ve cells. 
After 5 days of culturing with depleted conditioned media which had been exposed to 
the NDK proteins. The CD34+ve stem cells were FAC fixed and were screened under 
fluorescent activated cell sorting, to count the number of viable cells. CD34+ve cell 
surface markers are representative of primitive progenitor cells of haemopoietic 
lineages, which are capable of self renewal. 
Figure 19, shows the significant difference in CD34+ cell numbers between elution 
buffer control cultures and the cultures which were exposed to NDK protein from the 4 
bacterial species. A clear trend can be seen on the graphs.  
If we take into account the significance our the data obtained however, the p value 
indicates that the only significant result which accepts our hypothesis is that NM23-H1 
protein significantly increases the survival of CD34+ve cells compared with the elution 
buffer control.  The p value for E. coli NDK protein indicates the significance of the 
results may be borderline significant, but still not enough to accept the hypothesis. The 
p value for the other bacterial protein reactions, indicate that the results are not 
significant. This variability could be due to umbilical cord sample variability. 
In the study done by Andrew Lily, he noted that NM23-H1 proteins also promoted the 
proliferation of CD34+ve cells. However in our experiments, even though we have 
positively shown extended survival of CD34+ve cells, cells were harvested at less than 




Umbilical cord blood samples underwent 2 separate protocols. This was because 
bacterial NDK had not been investigated before and therefore it was decided to 
develop 2 protocols, one where we sort for CD34+ve cells and then the CD34-ve cells 
were sorted again for CD11b+ve cells. This was because the study undertaken by (Lilly, 
et al., 2011) had shown that CD11b+ve cells bind to the human NM23-H1 protein. The 
other protocol was where CD34+ve cells were sorted and CD34-ve cells were not 
sorted further but cultured straight with the NDK/NM23 protein. This was to see 
whether bacterial NDK proteins may bind to other cells within the CD34-ve population 
or whether they would act in the same way as NM23-H1.  
 The cord blood samples marked with a dashed line are samples which are not sorted 
for CD11b+ve cells. Despite it being hard to say; there does seem to be a lower cell 
number of CD34+ve cells where conditioned media was used from non sorted 











































Figure 18 Side Scatter Vs. Forward Scatter of CD34+ve viable cells 
Side scatter Vs. Forward scatter shows dead cells, viable CD34+ve cells and cytocount 
beads. 2uL of antibody were added to each sample. 
 
Isotype Control 
  Elution Buffer      NM23 
           E. coli            K.pneu 




Figure 19 CD34+ve Viability 
Cell survival was evaluated after 5 days of culturing with 2ug/mL of NM23-H1 or Bacterial NDK conditioned media or Elution Buffer only. 
The lines show the viability of treated samples compared to elution buffer control. Cells were seeded at 1x106/mL. Cord blood samples 
marked with a dashed line, show cord blood samples not sorted for CD11b+ve cells. 
* 
Please note CB samples 
2,3,7-15 did not contain 
enough CD34+ve stem 





4.10 NDK proteins directly promote the survival of CD34-ve 
cells  
CD34-ve cells (sample 1) were cultured with NDK protein for 11 days. CD34-ve cell 
numbers were assessed and the survival of CD34-ve cells was significantly higher in the 
cultures that had been incubated with NDK/NM23 protein, compared with elution 
buffer control. There was a significant difference in cell number, approximately 
between a 2 to 8 fold increase varying between the different NDK protein treatments. 
There is also variability between samples which could be due to variability in cord 
blood samples; and more umbilical cord blood analysis should be undertaken to 
determine a more significant result.  
FACs analysis was done to determine cell viability and cell surface expression for CD34, 
CD11b, CD3, CD19, CD14, CD33 and CD15, was obtained to determine which cells are 
surviving in the presence of NDK protein.  
From figure 21 you can see the cells surviving after 11 day culture with NDK proteins 
have significant expression for CD11b, CD3 and CD19. CD11b markers are expressed on 
many leucocytes, including monocytes, macrophages, natural killer cells, granulocytes 
and neutrophils. CD3 are expressed on T cells, CD19 on B cells.  
The micrographs (figure 23) of cells (sample 1) cultured with NDK proteins show a 
huge variation in cell population and viability, where cells cultured with elution buffer 
are scarce and contain mainly dead cells. Jenna Giemsa staining was done on 




cultured with NDK protein, look viable and healthy, with also cell differentiation. It is 
already been seen  from the previous experiments that NDK protein promotes the 
survival of CD34+ and CD34-ve cells, however from the Jenna Giemsa stained 
micrographs the presence of red blood cells in NDK protein cultured samples are 








































Figure 20 Side Scatter Vs. Forward Scatter of CD34-ve viable cells 
Side scatter Vs. Forward scatter shows dead cells, viable CD34-ve cells and cytocount 




Elution Buffer NM23 

































Figure 21 FACs Analysis of CD expression markers in CD34-ve cell populations 
Dot plot analysis shows cell viability and expression for CD11b, CD34, CD33, CD3, 
CD15, CD14, and CD19. Isotype controls for each flurochrome. 2uL of antibody were 
added into each sample.   











































Figure 22 CD34-ve Viability of NDK treated cells 
Cell survival was evaluated after 11 of in culture with 2ug/mL of NM23-H1, Bacterial 
NDK or Elution Buffer only.  Each column shows the viability of treated samples 






















Cord Blood 16 - CD34-ve Cell 
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Cord Blood 17 - CD34-ve Cell 
Viability in Elution Buffer and 






























Figure 23 Micrographs of Jenna Giemsa stained CD34-ve cultured cells 
Micrographs of cells (sample 1) stained with Jenna Giemsa of cultured samples with elution buffer and NDK proteins, taken at x20 
magnification.
        Elution Buffer                     NM23-H1                                       E. coli 
    K.pneu                                   S.aur                                                 S.pneu 
      
68 
 
4.11 The survival of Leukaemic blast cells is varied amongst 
NDK protein treatment.  
Acute myeloid leukemic cells are cultured in ITS+ media with 2ug/mL of NDK protein, 
or elution buffer and harvested after 11 days. Without NDK protein the survival of cells 
in elution buffer only, were significantly lower compared with cell survival of cells 
treated with NDK protein. AML samples treated with E. coli and S. pneu NDK protein 
show an 8 fold increase in cell survival compared with elution buffer cultured cells, and 
cells treated with NM23-H1 and S.aur show about a 5 fold increase.  
Acute lymphoid leukemic cells were also cultured in ITS+ media with 2ug/mL of NDK 
protein or elution buffer, and harvested after 5 days. Cell survival of NDK treated 
samples were not very significant compared with elution buffer control. And if 






















Figure 24  AML Cell Survival 
Cells treated with 2ug/mL NDK protein or elution buffer control, harvested at day 11. 
Each column shows the viability of treated samples compared to elution buffer control. 
Cells were seeded at 1x106/mL. (n=3 for treatments with each NDK protein, however 

















Figure 25 ALL Cell Survival 
Cells treated with 2ug/mL NDK protein or elution buffer control, harvested at day 11. 
Each column shows the viability of treated samples compared to elution buffer control. 
Cells were seeded at 1x106/mL. (n=3 for treatments with each NDK protein, however 
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5. PART A CONCLUSION 
The results obtained from the indirect NDK protein assay with conditioned media from 
human NM23 protein, suggest that we were able to reproduce results that the human 
NM23-H1 protein does act as a survival factor for CD34+ve haemopoietic stem cells, as 
seen in the work by (Lilly, et al., 2011).  
The results obtained from the indirect NDK protein assays suggest a slight increase in 
the amount of viable stem cells present after 5 days of culturing with NDK protein 
conditioned media, and this is enough to indicate that with further work and 
optimisation of the purity protocols, with increased repeats on fresh cord bloods, that 
significant results may be obtainable. 
Previous studies have indicated how and also the importance of the human NM23-H1 
protein in cell survival, cell development and differentiation (Lombardi, et al., 2000).  It 
could be suggested that they may use bacterial NDK proteins in the same manner. This 
increase in viability of CD34+ve cells could have some therapeutic advantages as well 
as research advantages. 
The results obtained on the indirect leukaemic cell assays suggest that for the cell 
assays containing acute myeloid leukaemic cells cultured with NDK proteins from 
human NM23-H1 and bacterial NDK, show an increased survival compared with elution 
buffer control. However for the stem cell assays for acute lymphoid leukaemic cells 
cultured with NDK proteins, the results are quite different, and do not show a survival 




6. PART B INTRODUCTION 
Part B of this research project focuses on the characterisation of bacterial NDK 
proteins and determines whether point mutations or deletions within the conserved 
protein domains of NDK could affect the function of the protein.  
6.1 Previous Studies 
Previous literature has shown the NDK family, contain a number of conserved sites 
within the protein which play a role in function and structure of the NDK protein. NDK 
proteins from Mycobacterium tuberculosis were isolated and its hexameric structure is 
shown to play an important role in thermal stability (Georgescauld, et al., 2013). In a 
study by (Sundin, et al., 1996) 4 mutations within the NDK protein of Pseudomonas 
aeruginosa were isolated and results indicated a loss in biochemical activity. In an 
Escherichia coli strain knockout, NDK bacteria were isolated and results indicated a 
greater number of mispaired bases within the cell indicating a role for NDK in DNA 
replication. Double mutants lacking both the NDK gene have base substitutions 15 fold 
higher than wild type (Miller, et al., 2002). These higher levels of base substitutions 
and mispairs; and the secretory ability of certain bacteria to release NDK proteins out 
of its cell into host environments leads to the question as to whether bacterial NDK like 
the human NM23 homology has an association with cancer and whether bacterial NDK 





6.2 Aims of the project 
The aim of this study is to characterise bacterial NDK proteins from species commonly 
known to cause infections in cancer patients.  NDK KO Escherichia coli will be produced 
and site directed mutagenesis will be used on several conserved domains within the 
protein structure in Escherichia coli to determine the importance of the function and 





7. PART B METHODS AND MATERIALS 
7.1 cDNA Production 
7.1.1 Primer Design 
 A web tool Primer 3 was used to automatically construct a forward and reverse primer 
set for Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and 
Streptococcus pneumoniae NDK proteins, from each bacterial NDK coding sequence. 
Conditions were set at; melting temperature 60oC, GC ratio 50%, primer size optimum 
20bp, and product size range between 200 and 500bp. Primer designs can be found in 
appendix 
7.1.2 Growth Kinetics 
Growth kinetics analysis was done to determine mid -logarithmic and stationary phase 
of each bacteria. Overnight cultures were made for each bacterial species, by 
inoculating 5 mL LB broth with Escherichia coli, pseudomonas aeruginosa and 5mL MH 
broth with Staphylococcus aureus. Overnight cultures were diluted 1 in 100 the next 
day and 200 uL of diluted bacterial were added in replicate to a 96 well plate and 













































SA 1 SA 2 SA 3 
B 
C 
PA 1 PA 2 PA 3 
   
D    
E       
F       
G       
H       
EC = Escherichia coli  PA = Pseudomonas aeruginosa    
SA= Staphylococcus aureus 
Table 4 Plate layout for Growth Kinetics 
7.1.3 RNA Extraction 
Overnight cultures for each bacterial species are incubated at 37oC in a shaking 
incubator. Overnight cultures were done in Lysogeny Broth (LB) broth for Escherichia 
coli and Klebsiella pneumoniae, in Muller Hinton (MH) broth for Staphylococcus aureus 
and Brain Heart Infusion (BHI) Broth for Streptococcus pneumoniae.  Streptococcus 
pneumoniae was also grown in a static incubator.  
The following day these were diluted 1 in 25 into 5mL and the remainder of the 
overnight culture was stored in the static incubator. These were then left to grow for 
approximately 2 and ½ hours or until their OD was between 0.4-0.6. This information 




Once we have bacterial growth to mid-logarithmic and at stationary phase, 4mL of 
each culture was added to clearly labelled falcon tubes, decipherable between mid-
logarithmic and stationary phase cultures and species. 1mL of phenol (5%): ethanol 
(95%) was added, and the mixture was incubated on ice for 30 minutes.  Samples were 
then centrifuged at 4oC at maximum RPM for 10 minutes. Supernatant was discarded 
into phenol waste, and pellet was resuspended in remaining liquid 
N.B. Streptococcus pneumoniae was not grown overnight, due to them undergoing 
autolysis at stationary phase. Streptococcus pneumoniae was grown for 6 hours. At 3 
hours the OD of the cultures were checked. When an OD of 0.2 was reached 
(beginning of stationary phase) 4mL of culture was added to phenol (5%): ethanol 
(95%) and incubated on ice for 30minutes. The cell suspension was centrifuged at 4oC 
at maximum RPM for 10 minutes and supernatant discarded. The pellet was stored at -
80oC overnight. At 6 hours, when an OD of 0.9 has been reached, 4mL of culture was 
added to phenol (5%): ethanol (95%) and incubated on ice for 30minutes. Suspension 
was pelleted and supernatant discarded. The Pellet was stored at -80oC overnight. RNA 
extraction was obtained following the protocol explained in detail below.  
 Samples were transferred into labelled eppendorfs and centrifuged using a desk top 
centrifuge for 60 seconds at maximum speed. Remaining fluid was discarded and pellet 
was resuspended in 100uL TE buffer with 50mg/mL lysosyme.  
N.B. for Staphylococcus aureus lysostaphin enzyme (Sigma Aldrich) was used to break 
open the cell walls. A Sonication step was added to aid in the lysing process and RNA 




Samples were incubated at RT for 5 minutes. 75ul lysis reagent was added and gently 
mixed by inversion. 350uL RNA dilution buffer added, mixed by pipetting up and down. 
Samples were added to a heat block at 70oC for 3 minutes. Samples were vortexed and 
centrifuged for 10 minutes at maximum RPM. A while pellet formation was an 
indication that bacteria have been lysed. Samples were transferred into fresh 
eppendorfs, ensuring no white pellet formation was transferred over. 200uL of 95% 
ethanol was added and samples mixed by pipetting up and down.  
Samples were transferred into a spin column and centrifuged for 30 seconds, eluates 
were discarded. 600uL of wash buffer was added and samples were centrifuged for 30 
seconds at maximum RPM. Eluates were discarded and 10uL of commercially bought 
DNAse mix containing MnCl2, DNAse core buffer and DNAse was added to the spin 
column and incubated at RT for 15 minutes. 200uL DNAse stop solution was added and 
samples centrifuged for 30 seconds. 600uL wash buffer was added to the samples, 
centrifuged and eluates discarded. 250uL wash buffer was added, and samples 
centrifuged, and eluates discarded. Samples were spun dry, and then spin columns 
were placed into a fresh eppendorfs. 100uL RNAse free H20 was added, and left to 
stand for 1 minute. Samples were centrifuged for 2 minutes at maximum RPM. And 
RNA extracted was stored in the freezer. 
5uL of each sample was run on a 1% agarose gel at 100V for approximately 30 minutes. 





7.1.4 cDNA synthesis using Superscript III 
The following reagents were added into a nuclease free micro centrifuge tube; 2ug 
RNA in RNAse free water, 1uL 50ng/uL random primers, and 1uL 10nM dNTP mix,  
The RNA for each bacterial species was quantified using gene tool, based on the gel 
separation results, determining the volume or RNA in solution required to make up 
2ug.  
For example: 
 Quantity in ng Quantity to 2ug Volume to 11uL 
E. coli mid-
logarithmic 1  











E. coli Stationary 288.7863 2000/2.88.7863 11-
(2000/2.88.7863) 
E. coli Stationary 518.9769 2000/518.9769 11-
(2000/518.9769) 
 
Table 5 Quantification of cDNA 
 
 The mixture was then heated at 65oC on a heat block for 5 minutes, and incubated on 




1uL RNAse OUT, and 1uL superscript III RT was added per sample. 7uL of master mix 
was added to each sample, mixed gently up and down and incubated for 5 minutes at 
RT. Samples were incubated on a heat block at 50oC for 1 hour, and reaction 
inactivated by heating at 75oC for 15 minutes.  
7.1.5 Real Time PCR for cDNA amplification 
cDNA was then amplified by Real-Time PCR. cDNA was diluted 1 in 10 and 1 in 1,000. 
Each PCR mix contains; 22.5uL of commercially ready PCR mix, 0.75uL of a 25uM 
working stock of Forward and 0.75uL of Reverse primers, and 1uL of cDNA template.  
Primers used were specific to each species: 16s gene Primers (strain control) and NDK 
gene Primers were used.  
N.B. for S. pneumoniae control primers rpoB gene primers were used as a control to 
show efficient expression of cDNA.  
PCR Conditions: 
95oC  --> 5 minutes (denaturation) 
95 oC  --> 30 seconds (denaturation) 
50 oC  -->  30 seconds (primer annealing)  x 30 Cycles.  
72 oC  -->  30 seconds (primer extension) 
72 oC  -->  10 minutes (final extension) 
4 oC  --> hold.  
 
Amplify cDNA in neat form, 1 in 10 dilution and 1 in 1,000 dilution were check by gel 




NDK and bacterial control cDNA from each bacterial species was quantified using gene 
tool, to determine whether NDK DNA was expressed all the time and whether they 
differ in quantity at mid-logarithmic and at stationary phase.  
7.2 Construction of NDK Knockout in Escherichia coli using 
Datsenko and Wanner Method 
7.2.1 Primer Design 
A web tool Primer 3 was used to automatically construct knock out forward and 
reverse primer set for Escherichia coli from the bacterial NDK coding sequence. On the 
end of the NDK KO primers, a sequence matching the Kan cassette was added.  
 Conditions were set at; melting temperature 60oC, GC ratio 50%, primer size optimum 
20bp, and product size range between 200 and 500bp. Primer designs can be found in 
appendix 
7.2.2 GeneJet Plasmid miniprep of pkd46 and pkd4 
The pkd46 plasmid which contains an ampicillin resistance gene was used as a 
antibiotic resistance marker within the knockout production, and the pkd4 plasmid 
which contains a kanamycin cassette and was used as a PCR template to replace the 
NDK gene. 
Any strain containing pkd46 plasmid, in this case (L642) and pkd4 plasmid in this case, 
(I633) was grown overnight on LB plates containing 50ug/mL of ampicillin, and LB 




The following day L642 and I633 were grown in (separate) 5mL LB broth with 50ug/mL 
AMP, and LB broth with 50ug/ml kanamycin respectively at 37oC in the shaking 
incubator overnight.  
 The overnight cultures were centrifuged at 4oC for 10 minutes at 3000 RPM, and the 
pkd46 and pkd4 plasmids were purified out of the L642 Salmonella strain and the I633 
E. coli strain the next day, using thermo scientist GeneJet Plasmid miniprep kit, 
following manufacturer’s instructions. Purified plasmid DNA was stored at -20oC. 
5uL of sample was run on a 1% agarose gel for 40 minutes at 100V to check purity and 
quantity of plasmid prep.   
7.2.3 Transformation of recipient strain I364 with pkd46  
I364 was a laboratory strain of K-12 E. coli,   
I364 wild type were transferred into 5mL of LB broth and grown at 37oC until 
logarithmic phase (OD 0.4) was reached. The culture was then centrifuged at 3000 
RPM at 4oC for 10 minutes. It was crucial that everything was done on ice. Glycerol was 
kept on ice prior to resuspension.  Supernatant were discarded and the pellet 
resuspended in 1mL of 15% glycerol, step repeated and final pellet was resuspended in 
500uL of 15% glycerol. Into a pre chilled electroporation cuvette 50ul of cell 
suspension was add as well as 2uL of pkd46 purified plasmid.  Sample was 
electroporated at 2.5Kv. 1mL of LB broth was added into the cuvette after 
electroporation and placed into a universal to revive cells.  Competent cells were left in 




plate and onto an LB plate with 50ug/mL ampicillin and left to grow at room 
temperature for 2 days.  
Streaking competent I823 cells onto an LB plate was used to check that the cells were 
still alive. Streaking on to an LB plate with ampicillin was used to check that the 
competent cells have incorporated the pkd46 plasmid, as pkd46 contains an ampicillin 
resistant marker, and therefore should only grown on the ampicillin resistant plate if 
they have incorporated the pkd46 plasmid.   
Transformation was checked by purifying plasmid using GeneJet miniprep kit, following 
manufacturer’s instructions.   
7.2.4 Kanamycin cassette PCR amplification 
Pkd4 plasmid used as DNA template for NDK knockout production. The NDK knockout 
primers were designed for the amplification of the kanamycin cassette within the pkd4 
plasmid. The NDK knockout primers contain a complement sequence for the 
kanamycin cassette and compliment sequence for the NDK gene, which will be used to 
encourage the ‘swapping’ of the NDK gene with the kanamycin cassette when 
electroporated into the recipient knockout strain.   
NDK knockout primers (shown in appendix) were reconstituted in RNAse free water, 
and a working stock of 25uM used in the following experiment.   
Each PCR mix contains; 22.5uL of commercially ready PCR mix, 0.75uL of a 25uM 






95oC  --> 5 minutes (denaturation) 
95 oC  --> 30 seconds (denaturation) 
50 oC  -->  30 seconds (primer annealing)   x 30 Cycles.  
72 oC  -->  1 minute and 30 seconds (primer extension) 
72 oC  -->  10 minutes (final extension) 
4 oC  --> hold.  
 
Amplified pkd4 plasmid was separated on a 1% agarose gel to check amplification of 
plasmid has worked.  
7.2.5 Electroporation of I823 and I365 E. coli with pkd4 KO constructs 
I823 and I365 containing pkd46 plasmid were transferred in 5mL LB broth containing 
50ug/ml ampicillin and incubated over night at 30oC. The following day 10mM 
arabinose, 50ug/mL AMP was added to 10mL of LB media and inoculated with 400 uL 
of overnight culture and incubated with aeration at 30oC for 4 hours, until an OD600 
was reached. Cells were harvested by centrifugation at 3,000 x g for 10 minutes at 4oC, 
supernatant was discarded and bacterial pellet resuspended in 1ml of 15% ice cold 
glycerol and centrifuge at 3000 x g for 10 minutes at 4oC, this step was repeated twice. 
Final pellet was re-suspended in 500uL of 15% ice cold glycerol. Competent cells were 











Table 6 Knockout Construct Quantities 
50uL of competent cells were added to a pre-chilled 0.2cm electroporation cuvette, 
into 3 separate electroporation cuvettes, either 2ng, 5ng or 10ng of KO construct was 
added. The electroporator was set to 2.5kV and samples were pulsed with electricity 
for approximately 5 seconds. To recover cells, the electroporated cells were incubated 
in 1mL of LB media for an hour at 37oC. 400uL of recovery mixture was plated onto LB 
plates containing 50ug/mL kanamycin. Plates were incubated for 2 days at 37oC. This 
allows the for the loss of the pkd46 plasmid which was temperature sensitive.  
 
The NDK knockout production by Datsenko and Wanner method failed on 3 attempts, 
and due to time constraints it was decided that the p86 F6 NDK KO from the culture 




7.3 Transduction of p86 F6 NDK Knockout into I364 using p1 
phage 
7.3.1 Production of p2 bacteriophage  
 
Prior to P2 bacteriophage production with p86 F6 NDK knockout. Phage assay was 
carried out to determine the ability of phage to lyse and infect the I364 E. coli strain. 
This was carried out by spreading I364 E. coli on to a an LB plate. 5uL of P1 phage was 
added to the plate along with 5uL of P22 Salmonella bacteriophage as a control (this 
should not lyse and infect E. coli) and left to grow overnight at 37oC. The following day 
the formation of a plaque indicates successful lysis of bacteria.  
p86 F6 NDK KO in 5mL of LB media was grown overnight at 37oC. The following day 
culture was diluted 1:100 into 5mL of fresh LB media containing 10mM of MgSO4 5mM 
CaCl2 and aerated for 30minutes at 37
oC. 5uL of P1 bacteriophage was added and 
culture was grown overnight at 37oC in shaking incubator.  The following day overnight 
was transferred into 50mL falcon tube and 1mL of chloroform was added. Suspension 
vortexed well for 15 seconds, and then centrifuged at 4,000 RPM at 4oC for 10 
minutes. Supernatant was transferred into a glass bottle (as chloroform attacks 
plastic); a further 200uL of chloroform was added and stored at 4oC.  
Transductions were screened by PCR and 1 successful colony was cultured on a plate 





7.3.2 P2 Transduction into I364 
 
I364 E. coli was grown up in 5mL LB media at 37oC. The following day the cultures were 
spun at 4,000 RPM at room temperature for 5 minutes and resuspended in 1mM 
MgSO4 and 5mM CaCl2. Transductions were set up using different volumes of phage 
lysates. See table below. 






Table 7 Transduction Quanties 
In 4, 1.5mL Eppendorfs add 100ul of I364 cells and add the different quantities of 
phage lysates to consecutive tubes. Tubes were incubated for 15 minutes at 37oC in 
heat block. 100uL of 1M sodium citrate and 1mL LB media was added and cells 
incubated for a further 45minutes at 37oC. 100uL of cell suspension was plated out 
onto LB plates containing 50ug/mL kanamycin to select for transductants. Plates were 
incubated for 2 days at 37oC. 
To check for successful transduction of NDK KO into I364 background strain, colonies 
were streaked onto a fresh plate, and the following day, were amplified by PCR, using 
NDK KO check primers. PCR reaction mix was made up with 22.5uL Reddy mix, 0.75uL 




template and a positive control using pET15b NDK EC Bl21 DE3 used as a positive 
control for NDK.  
 
PCR Conditions: 
95oC  --> 5 minutes (denaturation) 
95 oC  --> 30 seconds (denaturation) 
50 oC  -->  30 seconds (primer annealing)    x 30 Cycles.  
72 oC  -->  2 minute (primer extension) 
72 oC  -->  10 minutes (final extension) 
4 oC  --> hold.  
Successful transducts were stored in protect beads at -20 oC 
Transductions were screened by PCR and 1 successful colony was cultured on a plate 
and stored on protect beads.  
7.4 Quikchange II Site Directed Mutagenesis 
7.4.1 Primer Design 
 
A web tool Quikchange mutagenesis Primer design was used to automatically 
construct a forward and reverse primer set for point mutations and deletions in the 
NDK gene of Escherichia coli. Conditions were set at; melting temperature 60oC, GC 
ratio 50%, primer size optimum 20bp, and product size range between 200 and 500bp.  




7.4.2 Mutant Strand synthesis reaction 
 
pET15b plasmid was purified using GeneJet Plasmid miniprep kit (Thermo Scientific) 
following manufacturer’s instructions. The pET15b plasmid was used as the template 
plasmid for site directed mutagenesis.  
Conditions for the synthesis of 2 complimentary oligonucleotides of Escherichia coli 
NDK with desired mutations according to manufacturer’s instructions were as follows;  
Control reaction: 5ul 10x Reaction buffer, 2ul (10ng) pWhitescript 4.5kb control 
plasmid, 1.25ul (125ng) control forward and reverse primers, 1uL dNTP mix, 38.5ul 
dH20 and 1uL PfuUltra HF DNA polymerase. 
Sample reaction: 5ul 10x Reaction buffer, 1ul (100ng) pET15b 45.7kb plasmid, 1.25ul 
(125ng) pET15b mutant forward and reverse primers, 1uL dNTP mix, 38.5ul dH20 and 
1uL PfuUltra HF DNA polymerase.  
Please note the site directed mutants desired in the following protocol consist of 
changes at the following sites:- 
M A I E R T F S I I K P N A V A K N V I G N I F A R F  E A A G F K I V G T K M L H L T V E Q A R G F Y 
A E H D G K P F F D G L V E F M T S G P I V V S V L E G E N A V Q R H R D L L G A T N P A N A L A G 
T L R A D Y A D S L T E N G T H G S D S V E S A A R E I A Y F F G E G E V C P R T R 
KP to AA a31g_a32c_c34g 
G to A g236c 





PCR Conditions according to manufacturer’s instructions – 
 
95oC  --> 30 seconds (denaturation) 
95 oC  --> 30 seconds (denaturation) 
55 oC  -->  30 seconds (primer annealing)  x 18 Cycles.  
68 oC  -->  6 minute  (primer extension) 
4 oC  --> hold.  
After thermal cycling samples were placed on ice for 2 minutes so that the reaction can 
be cooled to approximately 37oC before proceeding to the next step. 
N.B. In the production of Site Directed Mutagenesis the thermal cycling conditions 
were optimised to the following;  
95oC  --> 30 seconds (denaturation) 
95 oC  --> 30 seconds (denaturation) 
68 oC  -->  10 minutes (primer annealing)  x 25 Cycles.  
68 oC  -->  6 minute (primer extension) 
4 oC  --> hold.  
Annealing temperature was changed to 68oC and time changed to 10 minutes. The 
number of cycles was also changed to 25.  
7.4.3 DpnI Digestion of amplified PCR product 
 
According to manufacturer’s instructions, the amplimers were digested by adding 1uL 




pipetting up and down, and then spun down in a bench top centrifuge at 15,000 RPM 
for 1 minute and immediately incubated at 37oC for 1 hour. This allows for the 
parental DNA plasmid to be digested.  
N.B. In the production of Site Directed Mutagenesis the digestion protocol was 
optimised by adding 2ul of Dpn I restriction enzyme and increasing the incubation time 
to 2 hours.  
7.4.4 Electroporation into alpha-select top 10 electrocompetent cells  
 
The alpha select top 10 electrocompetent cells were gently thawed on ice. 0.2ml 
electroporation cuvettes were pre-chilled on ice and 50ul of competent cells and 2uL 
of Dpn I digested DNA was added to the cuvettes. This was done for each mutagenesis 
reaction required. Electroporation of cells at 2.5kV were then recovered in 1mL of LB 
broth and incubated with aeration for 1 hour. A puC plasmid was also electroporated 
as a control as above. 400uL of the recovery mixture was plated onto ampicillin 
resistant plates and incubated at 37oC for 24 hours.  
Transductions were screened by PCR and 1 successful colony was cultured on a plate 
and stored on protect beads.  
7.4.5 Electroporation of SDM into I364 and I364 KO background 
 
I364 E. coli and I364 knockout E. coli were transferred and grown overnight in 5ml LB 
broth at 37oC with aeration. I364 knockout E. coli was grown in LB with 50ug/mL 




of fresh LB containing 50ug/mL kanamycin (in knockout strain only) and grown until 
mid-logarithmic phase was reached (OD 0.4). Once the cultures have reached mid-
logarithmic phase, the cultures were spun at 4oC for 10 minutes at 3,000 x g. 
Supernatant was discarded and pellet resuspended in 1mL of 15% glycerol.  The cell 
suspension was spun down at 3,000 x g for 10minutes at 4oC and pelleted resuspended 
in 15% glycerol. The following step was repeated and the pellet was resuspended in a 
final volume of 500uL of 15% glycerol.  
Site directed mutants were purified using GeneJet miniprep kit, (thermo scientific) 
following manufacturer’s instructions. 50uL of the competent cell suspension was 
added into a 0.2ml electroporation cuvette, and 2uL of purified SDM plasmid, 




SDM plasmids (2ul) 
I364 a31g_a32c_c34g 
I364 KO a31g_a32c_c34g 
I364 g236c 
I364 KO g236c 
I364 del307_315 
I364 KO del307_315 
 




Competent cells were electroporated at 2.5kV and recovered in 1mL of fresh LB broth 
and incubated at 37oC with aeration for 1 hour.  400uL of recovered cells were plated 
onto ampicillin (50ug/ml) LB plates and incubated at 37oC for 24 hours.  
The following days 4 colonies were picked at random from each plate and screened. 
The electroporated SDM plasmid in the I364 background was purified using GeneJet 
miniprep kit (thermo scientific) following manufacturer’s instructions and purified 
plasmids (5ul) were mixed with DNA loading buffer (2ul)  were run on a 1% agarose gel 
to determine the presence of the plasmid.  The electroporated SDM plasmid in the 
I364 KO background was screened using PCR using E. coli NDK primers to amplify NDK 
mutant within the pET15b plasmid only.  
Reaction mix x1: 22.5uL PCR Reddy Mix, 0.75uL forward and reverse primers, 1uL 
template. 
PCR conditions:  
95oC  --> 5 minutes (denaturation) 
95 oC  --> 30 seconds (denaturation) 
50oC  -->  30 seconds (primer annealing)  x 30 Cycles.  
72 oC  -->  1 minute (primer extension) 
72oC  --> 10 minutes (final extension) 
4 oC  --> hold.  
5ul Amplimers were run on a 1% agarose gel to determine the presence of NDK 
mutant in pET15b plasmid. The presence of the NDK mutant in pET15b plasmid on the 




7.5 Protein expression of r-NDK mutants 
The following cells were cultured overnight in 5mL of LB broth I (containing 50ug/ml 
appropriate antibiotic) at 37oC with aeration 
 
Mutant/Control Background Antibiotic 






pET15b EC NDK 
a31g_a32c_c34g 
 
I364 KO Ampicillin 





pET15b EC NDK g236c 
 
I364 KO Ampicillin 
pET15b EC NDK del307_315 I364 
 
Ampicillin 
pET15b EC NDK del307_315 
 
I364 KO Ampicillin 
pET15b EC NDK  BL21 (DE3) 
 
Ampicillin 














Table 9 rNDK mutants for protein expression 
 
The following day samples were diluted 1:50 into fresh LB broth including appropriate 
antibiotic (10uL in 5ml).  2x pET15b EC NDK (one to be induced and one none induced) 
and incubated with aeration at 37oC until an OD 0.4 was reached. Once an OD of 0.4 
was reached 1mmol of IPTG was added to the following cultures and incubated at 37oC 


















pET15b EC NDK g236c 
 
I364 KO 
pET15b EC NDK del307_315 I364 
 
pET15b EC NDK del307_315 
 
I364 KO 
pET15b EC NDK (induction) BL21 (DE3) 
 
 
Table 10 rNDK mutants for IPTG induction 
The following cultures were not induced but were incubated under the same 
conditions as the induced samples. 
















Table 11 rNDK non induced protein samples 
The following day 1mL of each culture was pipette into a clean universal, clearly 
labelled and spun down at 4oC for 10 minutes at 3,000 x g. 150ul of supernatant was 
pipette into a clean eppendorf and mixed with 50uL of 4xGLB (recipe can be found in 
the appendix). The remaining supernatant was discarded and the bacterial pellet 




pellet was then denatured at 91oC using the heat block for 5 minutes. Once the 
bacterial cells have been denatured to release the intracellular protein, the samples 
were spun down for 1 minute on a bench top centrifuge at 15,000 RPM to pellet the 
cell debris.  
Pre-bought BOLT Bis-Tris 4-12% Protein Gels (Life technologies) were loaded with 20uL 
of each intracellular protein sample and supernatant. 5uL of protein ladder was added 
to the first well. The Gel was run at 150V for approximately 40minutes to separate 
proteins according to mass, until GLB has reached the bottom line on the gel. After the 
proteins have been separated, the gels were washed in 20mL of ultra pure water in a 
square petri dish, placed on bench top shaker at 20RPM, for 5 minutes. This was 
repeated 3 times, before gels were stained in safe stain (20ml) for 1 hour. Gels were 
then washed in 20ml ultra pure water, for 1 hour, then fresh ultra pure water (20ml) 





7.6 Protein Modelling using Swiss Modelling software.  
 
SWISS model, Swiss institute of Bioinformatics used to predict models for NDK by using 
the protein alignments of the SDM mutants and wild type E. coli for the following. 
NDK Wild Type 
MAIERTFSIIKPNAVAKNVIGNIFARFEAAGFKIVGTKMLHLTVEQARGFYAEHDGKPFFDGLVEFMTSGPIV
VSVLEGENAVQRHRDLLGATNPANALAGTLRADYADSLTENGTHGSDSVESAAREIAYFFGEGEVCPRTR 
Mutant 1: SDM a31g_a32c_c34g  
MAIERTFSIIAANAVAKNVIGNIFARFEAAGFKIVGTKMLHLTVEQARGFYAEHDGKPFFDGLVEFMTSGPIV
VSVLEGENAVQRHRDLLGATNPANALAGTLRADYADSLTENGTHGSDSVESAAREIAYFFGEGEVCPRTR 
Mutant 2: SDM g236c 
MAIERTFSIIKPNAVAKNVIGNIFARFEAAGFKIVGTKMLHLTVEQARGFYAEHDGKPFFDGLVEFMTSGPIV
VSVLEAENAVQRHRDLLGATNPANALAGTLRADYADSLTENGTHGSDSVESAAREIAYFFGEGEVCPRTR 







First gland by Jmol was used to highlight the conserved domains that were mutated. 
This was done by uploading the PDB file created by SWISS model, and then using the 







8. PART B RESULTS  
8.1 Growth Kinetics 
Bacterial growth kinetics was done on Escherichia coli, Klebsiella pneumoniae and 
Staphylococcus aureus was done prior to RNA extraction to determine when the 
bacterium has reached mid-logarithmic growth phase. Using fluostar growth kinetics 
analysis this can be determined both in time and in optical density.  
Streptococcus pneumoniae has not tested as S. pneumoniae autolyse itself when it gets 
to stationary phase.  
 Looking at the growth kinetics results shown in figure 1, mid-logarithmic growth was 
achieved at approximately 2 ½ hours (OD 0.2-0.4) for E. coli, 1 ½ hours (OD 0.2-0.4) for 







Figure 23 Growth Kinetic Analysis of Escherichia  coli, Klebsiella pneumoniae and 
Staphylococcus aureus 
Figure 27 shows the growth of Escherichia coli, Klebsiella pneumoniae and 
Staphylococcus aureus in LB media, grown over a 16.5 hour period with an absorbance 






















Growth Kinetic Analysis of Escherichia coli, 
Klebsiella pneumonaie and Staphylococcus 
aureus 




8.2 Gene Expression 
 
To determine NDK expression at mid-logarithmic and stationary growth phase, RNA 
was extracted from the 4 bacterial species from overnight cultures. Figure A shows the 
presence of RNA extracted from the 4 bacterial species, the 2 bands were indicative of 
28S and 18S ribosomal RNA species. The 28S band should appear brighter, however if 
the 18S bands appears brighter it could be due to the presence of excess DNA within 
the sample. This can be seen in RNA extraction of E. coli and S. pneumoniae. A smudge 
through the well was indicative of messenger RNA, which can be seen quite strongly in 
the RNA extraction of S. aureus. The RNA extraction gel of S. aureus appears to not 
have any bands of ribosomal RNA; however the quantification shows that ribosomal 
RNA has been extracted just in a smaller quantity. Regardless of the differences in 
quantity (shown in figure B) of RNA extracted from the 4 different species of bacteria, 
we were able to obtain enough RNA to perform cDNA synthesis.  
Figure B shows the quantification of RNA, using gene tool, Syngene, and the 
conversions to determine the quantity of RNA extracted required in a 2ug 
concentration of a final volume of 11ul. RNA extraction was done in replicates; this 
was to ensure a successful quantity of ribosomal RNA for cDNA synthesis. The rows 
highlighted in blue, indicated an insignificant amount of RNA extracted, and therefore 
these samples were not used in the synthesis of cDNA.  
Figure C shows cDNA synthesis of 16S cDNA, and NDK. 16S was a house keeping gene 




proteins. It was therefore useful as a positive control to ensure the synthesis protocol 
was working sufficiently. A rpoB gene was used as a positive control in s. pneumoniae, 
only because we had a primer set available for use. The rpoB gene codes for a beta-
subunit of bacterial RNA polymerase and was therefore a house keeping gene found in 





A  RNA Extraction from Escherichia coli, Klebsiella pneumoniae, Staphylococcus 




















































S. Pneumoniae R6 





















B   Quantification of RNA using Gene Tool. 
 
Escherichia coli Quantity/ng Vol (ul) in 2ug Vol of dH20  
  
  
2000/quantity final Vol = 11ul 
  1 572.73 3.49 7.51 
mid-log' 2 717.17 2.79 8.21 
  3 678.60 2.95 8.05 
  1 16.24 123.12 -112.12 
Stat 2 288.79 6.93 4.07 
  3 518.98 3.85 7.15 
     Klebsiella pneumoniae Quantity/ng Vol (ul) in 2ug Vol of dH20  
  
  
2000/quantity final Vol = 11ul 
  1 676.96 2.95 8.05 
mid-log' 2 786.54 2.54 8.46 
  3 570.01 3.51 7.49 
  1 325.26 6.15 4.85 
Stat 2 289.78 6.90 4.10 
  3 0.00 - - 
     Staphylococcus aureus Quantity/ng Vol (ul) in 2ug Vol of dH20  
  
  
2000/quantity final Vol = 11ul 
  1 405.36 4.93 6.07 
mid-log' 2 5941.74 0.34 10.66 
  3 16775.79 0.12 10.88 
  1 227.40 8.80 2.20 
Stat 2 256.65 7.79 3.21 
  3 248.21 8.06 2.94 
     Streptococcus pneumonaie Quantity/ng Vol (ul) in 2ug Vol of dH20  
  
  
2000/quantity final Vol = 11ul 
  1 62.61 3.19 7.81 
mid-log' 2 18.08 11.00 0.00 
  3 - - - 
  1 32.48 6.16 4.84 
Stat 2 32.33 6.19 4.81 















C  cDNA synthesis using superscript III and random primers. 
 
 
Figure 24 NDK Gene Expression of Escherichia coli, Klebsiella pneumoniae, 
Staphylococcus aureus and Streptococcus pneumoniae 
Figure 28 shows the NDK gene expression at mid-logarithmic and at stationary 
bacterial growth phase compared with control gene expression. (A) RNA extraction, 5ul 
of sample separated on 1% agarose gel. (B) RNA quantification using gene tool, to 
determine the volume of each sample required in 2ng of RNA for cDNA production. (C) 
cDNA expression of control gene and NDK gene at mid-logarithmic and stationary 
phase, neat, 1 in 10 and 1 in 100 dilution, to ensure cDNA quantification was obtained 


















































8.3 Mid-logarithmic and Stationary phase cDNA expression of 
NDK  
cDNA synthesis of NDK for the 4 species of bacteria was obtained from RNA at mid-
logarithmic and at stationary phase. In figure 3 the expression of NDK at mid-
logarithmic and at stationary phase were compared, expression values we’re corrected 
for using the control cDNA quantities and results were shown as a percentage, where 
mid-logarithmic growth was marked at 100% and stationary phase was calculated to 
be either higher or lower depending on the cDNA quantification values. Values were 
only obtained from unsaturated bands, to determine an accurate cDNA value. In 3 of 
the 4 bacterial species dilution 1:10 was used to determine the percentage expression 
of cDNA at stationary phase. In K. pneumoniae expression was calculated from neat. 
The graph shows quite clearly that NDK was expressed nearly 3 fold more at stationary 
phase than at mid-logarithmic phase in e. coli, and nearly 2 fold at stationary phase in 















Figure 25 Bacterial NDK Expression at mid-logarithmic and stationary growth phase 
Figure 29 shows the expression of NDK of E. coli, K. pneumoniae, S. Aureus and S. 
Pneumoniae at mid-logarithmic and at stationary growth phase. NDK expression was 
calculated by assuming NDK expression at mid logarithmic phase was calculated as 
100% and the stationary phase expression was calculated as a difference in percentage 
between mid logarithmic and stationary phase. Please see appendix 3 for workings for 
































Bacterial NDK Expression at mid logarithmic 
 and stationary growth phase 
 




8.4 NDK Knockout construction in Escherichia coli using 
Datsenko and Wanner Method 
To construct NDK gene knockout, I364 E. coli cells were prepared by transformation of 
pkd46 plasmid (figure A) which contains lambda recombinase, which helps in the 
targeted genetic changes in E. coli, i.e. ‘swapping’ of the NDK gene with a kanamycin 
cassette. The successful transformation of pkd46 plasmid into I364 E. coli cells was 
shown in figure B. Because the plasmid was super coiled it does not pass through the 
gel. Figure C shows the purification of pkd4 plasmid, which was isolated from a 
salmonella strain. Using primers complimentary to the kanamycin cassette, with an 
end sequence complimentary to the NDK gene, the kanamycin cassette within the 
pkd4 plasmid was amplified, (figure D) the amplified kanamycin cassette will have a tail 
nucleotide sequence which was complimentary to NDK; this will help with the gene 
knockout process.   
The kanamycin cassette was electroporated into the I364 E. coli with pkd46 plasmid 
shown in figure E, and grown over night in kanamycin LB plates. Successful colonies 
were screened using PCR with Knockout check primers, designed with a nucleotide 
sequence either side of the kanamycin cassette, thus the presence of a kanamycin 
cassette was indicative of a successful knockout. However the presence of NDK gene 
indicates unsuccessful gene knockout, which was shown in figure F. The knockout 
production was repeated several times. Primers were also used to determine whether 
the kanamycin cassette could have been inserted into another region of the bacterial 




cassette. Figure G shows that this was not the case as there was no presence of the 




























































































Figure 26 Schematic diagram of E. coli I364 K12 NDK knockout Construction 
Figure (A) shows the transformation of pkd46 (containing lambda red recombinase) 
plasmid into I364 E. coli cell. Figure (B) shows the purification of pkd46 plasmid from E. 
coli I364 to show successful transformation. Figure (C) shows the purification of pkd4 
plasmid, and figure (D) shows the PCR amplimers of the kanamycin cassette from the 
pkd 4 plasmid.  Figure (E) indicates the ‘swapping’ of NDK gene with Kanamycin 
cassette (knockout construct) during electroporation of background I364 strain 
containing pkd46 plasmid with knockout construct. Figure (F) shows amplimers of 
electroporated colonies grown on selective antibiotic (kanamycin) plates. Figure (G) 
shows the amplification of the kanamycin cassette using primers specific to the inside 


















L1 Kanamycin insert 





8.5P86 F6 NDK Knockout 
The production of NDK gene knockout was not successful.  A F6 p86 NDK gene 
knockout from a knockout library was obtained. To determine that the NDK knockout 
was a true knockout, PCR was done on selected colonies of 2 NDK knockout strains, 
using the knockout check primers, designed for the purposes of the previous 
experiment., shown in figure A.  In figure B,  bands were separated by gel 
electrophoresis, and it can be seen that for F5 p85are a mixture of wild type and 
knockout, where as F6 p86 were all true knockouts, shown by the band at 1.5Kbp 
(kanamycin cassette).  For the purposes of this project, all our work was done in e. coli 
I364 and therefore the F6 p86 NDK knockout was transduced into I364 cells, shown in 
figure C and D. Figure E shows the successful transduction of F6 p86 into I364, by the 
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Figure 27 schematic diagram of  p86 F6 NDK KO transduction into I364 
Figure (A) screen of F5 p85 and F6 p86 NDK knockouts from knockout library to 
identify ‘true’ knockouts. Figure (B) freshly streaked F6 p86 onto kanamycin plates re-
screened using kanamycin cassette check primers. Figure (C) production of p1 E. coli 
bacteriophage with F6 p86 Knockout DNA. Figure (D) transduction of p1 E. coli 
bacteriophage with I364 background strain. Figure (E) PCR amplification of selected 
colonies to show successful transduction.  
p1 E. coli phage














8.6 NDK Knockout Growth Kinetics 
Bacterial growth kinetics was done on Escherichia coli wild type and both knockout 
strains, to see whether the knockout of NDK influences the growth of E. coli. An 
absorbance reading was taken every 10 minutes for 16.5 hours. Figure 6 shows that 
knocking out the NDK gene, does not have an effect on the growth of Escherichia coli, 
the only notable difference was that the lag phase of the knockout bacterium was 
slightly increased, however all 3 strains grow to the same levels quite happily.  
 
 
Figure 28 Growth Kinetics for I364 NDK Knockout, p86 F6 NDK knockout compared 
with I364 Wildtype. 
Figure 32 shows the growth of E. coli I364 wild type and knockout mutants, to 
determine any differences in growth. Grown over a 16.5 hour period with an 
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8.7 Site Directed Mutagenesis 
To produce a site directed mutant, primers were designed with a single nucleotide 
change within the NDK sequence where the mutation was desired. These primers were 
used to synthesis 2 complimentary oligonucleotide sequences containing the desired 
mutation, Shown in figure A. A pET15b plasmid was used which already contains the 
NDK gene, ready to be mutated. The parental DNA was digested using Dpn 1 
restriction enzymes, show in figure B. The mutants were electroporated into alpha 
select competent cells and grown on a selective antibiotic LB plate. The pET15b 
plasmid contains an ampicillin resistant gene, and therefore electroporation of the 
plasmid will be indicative of bacterial growth on ampicillin plate (figure C). Colonies 
that grow on the ampicillin plates were sequenced to determine whether they were 
true mutants. Most plates only grew a couple of colonies, but sometimes these can be 
false positives. Figure D shows the sequence results of 3 successful mutants. The 
nucleotide substitutions/deletion was highlighted in each sequence, and also 





















































Figure 29 Schematic diagram  of Site Directed Mutant production 
Figure (A) thermal cycling and formation of complimentary oligonucleotides containing 
desired mutations. (full primer designs can be seen in appendix) Figure (B) Dpn I 
digestion of parental DNA. Figure (C) Electroporation of Dpn I treated mutant DNA into 
alpha-select competent cells. Figure (D) sequence results of successful site directed 
mutagenesis.  
  
Substitution KP11,12 – AA11,12





8.8 Electroporation of SDM into I364 and I364 KO background 
For the purpose of this project, all our work was done in Escherichia coli I364 strain, 
therefore all the mutants were electroporated into like strain, for an accurate 
comparison on further experimentations. Figure A shows the electroporation of SDM 
into competent I364 and I364 knockout backgrounds. Electroporated cells were grown 
on ampicillin resistant plates, and colonies grown were screened to determine 
whether the mutant has been successfully electroporated. The I364 KO background 
containing potential mutants, were checked by PCR using the E. coli NDK primer set to 
amplify the NDK gene, a positive result will indicate a successful electroporation, 
because the I364 KO strain will not contain the NDK gene within its chromosomal DNA, 
as it has been knocked out, shown in figure B. The I364 strain, because it contains its 
own NDK gene in its chromosome, cannot be screened in the same way. Therefore 
miniprep was done to purify the plasmid. A positive band for the plasmid indicates a 


























Figure 30 Electroporation of SDM into I364 and I364 KO background 
Figure A, electroporation of purified site directed mutants into I364 and I364 knockout 





Mutant 1 Mutant 2 Mutant 3 -ve 
I364        I364 K.O I364        I364 K.O       I364       I364 K.O
SDM









8.9 Protein expression of E. coli wild type and E. coli NDK 
mutants 
The expression of NDK protein from E. coli wild type and the E. coli mutants were 
compared. Cultures containing the Site Directed Mutants within the pET15b plasmid 
were induced along with the E. coli pET15b NDK wild type plasmid, with 1mmol of 
IPTG. The E. coli knockout and wild type was left to grow under the same conditions as 
the site directed mutant cultures, however without induction with IPTG, (because 
they’re not inducible with IPTG). After induction cultures were spun down and 
pelleted, cells were denatured to release intracellular protein and mixed with gel 
loading buffer. 20ul of supernatant containing any extracellular protein and denatured 
cell lysate containing intracellular protein were run on a 4-12% Bis-Tris Bolt protein gel.  
The mass of NDK falls approximately at 20kDa. From Figure 9 you can see clearly that 
the pET15b E. coli NDK which over expresses NDK, shows a definite band at 
approximately 20kDa, indicative of NDK. I364 wild type, you can see a faint band, 
indicative of NDK. It was not easy to establish whether the knockouts lack the NDK 
banding at 20kDa or not. It can also be observed that the site directed mutants 
contained within the pET15b plasmid, which should over express NDK when induced, 
like the pET15b NDK wild type, does not express NDK to the same levels as the wild 






















Figure 31 Protein Expression of E. coli Wild type and E. coli NDK mutants 
Figure 35 shows the differences in expression of E. coli wild type NDK, pEt15b over expressed E. coli NDK, E. coli NDK knockout mutants and E. 


























































































































Mutant 1 = a31g_a32_c34g,  Mutant 2= g236c,  Mutant 3 = del307_315 
      
 
8.10 Protein Models of NDK wild type and  
 
Protein modelling was used to determine whether there were any structural differences 
between wild type and the mutated NDK proteins. SWISS computer modelling was used to 
predict models of the structures for E. coli wild type and E. coli mutant NDK proteins.  
Protein alignments for each mutant and wild type were entered into an online database, 
used to calculate the structure of each protein.  
Mutant 1 and 2 show no structural differences between wild type and mutant NDK. This was 
as expected as these were just amino acid substitutions. Mutant 3 however, where 3 amino 
acid residues AA103 to AA 105 had been deleted shows a structural difference within the 


















Lysine11 (9 atoms) and 
Proline12 (7 atoms)
NDK E. coli Wild type 
monomer
Mutant 1
Alanine11 (5 atoms)  and 
Alanine12  (5 atoms)
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Figure 32 Predicted Protein Models of wild type and mutant NDK proteins 
Figure 36 shows predicted models for the 3 SDMs compared with wild type I364 NDK 
protein. Predicted models were made using SWISS model and mutated domains were 
highlighted using first glance in Jmol. 
  




9. PART B CONCLUSION 
This research project has shown that it was successfully possible to obtain NDK knockout 
mutant, as well as site directed mutants, over several conserved domains. It was possible to 
optimise protocols, over the problems that we faced, in obtaining these mutations.  
Mutated proteins were expressed and predicted structures for these proteins using 
computational modelling software were obtained. The protein expression gel shows the 
differences in the expression of induced and non induced NDK proteins of the different 
mutations, indicating that the mutation in the NDK conserved domains may play a role in 
the expression of the protein.  
Using the SWISS modelling software to predict the structure of the mutants, the only 
mutant to show a change in structure was the Kpn loop deletion mutant, this was a 






10.1 Can ‘normal’ stem cells use bacterial NDKs to promote their 
survival? 
To investigate the affects of bacterial NDK on ‘normal’ stem cells, recombinant bacterial 
NDK protein from Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and 
Streptococcus pneumoniae were cultured with umbilical cord blood CD34-ve cells, and the 
conditioned media depleted of NDK protein, were then cultured with CD34+ve cells.  
Previous studies show that NM23-H1 bind to more mature clones and not CD34+ve stem 
cells themselves. The culture of CD34-ve cells with NM23-H1 causes NM23-H1 to bind with 
CD11b+ve cells and the release of cytokines, which stimulate survival. (Lilly, et al., 2011)  
Taking this into consideration; we based our technique on the same principle that bacterial 
NDK proteins will bind to more mature CD11b+ve cells and release cytokines which will be 
cultured with CD34+ve stem cells to promote survival. 
However because bacterial NDK have not been investigated previously it was decided to not 
sort for CD11b+ve cells from umbilical cord blood, but to culture all CD34-ve cells with NDK 
protein; and observe viability. A second batch of umbilical cord blood samples were sorted 
for CD11b+ve cells, which where cultured with NDK protein.  
The results suggest that both techniques allow for a slight increase in viability; however this 
increase in survival was not significant through all the bacterial species, and reproducing the 
results would indicate whether these results can be significant enough to accept the 




survival and proliferation of umbilical cord blood stem cells and acute leukaemic 
progenitor cell.”  
The results obtained for the stem cell assay using NM23-H1 protein, showed to be 
significant, this confirms and reproduces results that have been seen before, (Lilly, et al., 
2011) For the survival of CD34+ve stem cells, however it was noted that in the stem cell 
assays, it was not possible to reproduce the results that Lilly et al, had produced to show the 
proliferation of stem cell growth not just increased survival. There were a few reasons why 
this could have been.  
 The samples which were not sorted for CD11b+ve had a lower viability rate than those that 
were sorted. This could be due to an ‘overcrowded’ population of cells which do not bind 
NDK protein, making it harder for CD11b+ve cells to bind. It was also observed while 
culturing that; samples that had been sorted for CD11b+ve cells had formed clusters of cells 
when treated with NDK; this observation was seen at a slower rate with samples cultured 
with full CD34-ve cell populations. One could also argue that culturing with a full CD34-ve 
population was closer to the microenvironment within a host, and therefore more likely to 
be an accurate representative model of what would occur in vivo.  
To analyse purity of our sorted samples, pre and post stains for CD34 was done on umbilical 
cord blood cells. Our FAC analysed post sort results show that our purity of CD34+ve 
samples, were not as pure as we would have liked. This could have been due to samples 
being ready for collection only towards to end of the day, and samples being kept in the 
fridge overnight and prepared only the morning after. With this suggested, consecutive cord 
blood samples were prepared the same day they were retrieved on. However results still 




retrieved in; contain a fixed amount of anti-coagulant, however this does not take into 
consideration the volume of cord blood received, and therefore if anti-coagulatant was 
insufficient in volume in relation to the volume of cord blood, cells will start to become 
‘sticky’ and clot, making the sort for CD34+ve cells harder. This could be overcome however, 
by doing a double sort, although this would put the cells under more stress; and therefore 
might cause a change in the viability of our CD34+ve cells.  
The results obtained suggest that we were able to reproduce results that the human NM23-
H1 protein does act as a survival factor for CD34+ve haemopoietic stem cells. However we 
were unable to produce significant results of whether bacterial NDK proteins do promote 
the survival of CD34+ve cells however the preliminary results, were enough to suggest that 
the stem cell assays with the bacterial NDK proteins were following a similar pattern to that 
of the human NM23-h1, and therefore a great repeat in stem cell assays, and optimisation 
of the purification of the stem cells, would help to produce significant results.    
Previous studies show that normal haemopoietic stem cells use human NM23-H1 protein 
for cell survival, development and differentiation. (Lombardi, et al., 2000) And it could be 
suggested that they may use bacterial NDK proteins in the same manner. This increase in 
viability of CD34+ve cells could have some therapeutic advantages as well as research 
advantages. 
The increased survival of CD34+ve cell in research, means that cells could be kept viable for 
longer, so that ongoing research can be done on 1 sample, this could also be an advantage 




An important advantage of increased survival of CD34+ve stem cells was in a therapeutic 
setting, for stem cell transplantation. Finding a stem cell match has been a challenge, with 
fewer than 30% of leukemic patients having HLA antigen sibling matches. An increased 
public population of bone marrow and stem cell donors were always pleaded for, and 
matches were always sought as close to the patient as possible, due to the low survival rate 
of stem cells in vitro. Increasing the survival of stem cells in culture media with conditioned 
CD34-ve cell media (treated with recombinant bacterial NDK) was a cheap way of keep cell 
alive. High concentrations of pure recombinant bacterial NDK proteins were easily produced 
in the laboratory. The results do suggest that not all bacterial NDK cause a significant 
increase in survival of stem cells; however E. coli NDK and K. pneumoniae NDK showed 
consistent increased survival similar to that of NM23-h1. 
After culturing of CD34-ve populations with NDK protein; samples were depleted of protein 
and cultured with CD34+ve cells. The remaining CD34+ve cells were left in the incubator. It 
was then discovered that cell survival of the CD34-ve population were still viable even after 
weeks. Investigations were done to look at the morphology of the cells surviving, cell 
surface markers were used to identify which cells were still viable, and viability counts were 
also done. The result showed a strong increase in viability compared with elution buffer 
controls. The Jenna Giemsa stained cells showed a healthy population of both differential 
leucocytes and erythrocytes, in samples cultured with NDK protein, and dead matter was 
mainly seen in elution buffer controlled samples. The cell surface marker investigations 
suggested that the viable cells consisted of macrophages, monocytes, neutrophils, T cells 
and B cells. It would be of interest to find out whether these cells had immune function; and 




10.2 Does bacterial NDK contribute to the survival of leukaemic 
cells?  
To investigate the affects of bacterial NDK on leukaemic cells, recombinant bacterial NDK 
protein from Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and 
Streptococcus pneumoniae were cultured with acute myeloid cells and separately with acute 
lymphoid leukaemic cells.  
Previous research has shown that NM23-H1 found in the blood aids in the proliferation and 
survival of AML cells. AML samples have been shown to have an increased expression of 
NM23-H1 compared with normal control samples and studies have shown that only 60% of 
AML cells actually bind NM23-H1. It was not understood fully why not all leukaemic clones 
bind NM23.  (Okabe-Kado, et al., 2009) Early progenitor cells express NM23-H1 cells; more 
so than more mature haemopoietic cells. The cycle of leukaemic survival could be suggested 
by a similar mechanism to that of normal haemopoietic stem cell survival. The increased 
proliferation of leukaemic blast cells into the blood causes an increased expression of 
NM23-h1, this over expression of NM23-H1, bind to more mature CD11b+ve cells causing  
the release of cytokines and therefore promoting the survival of AML CD34+ve cells.  
The results suggest that acute myeloid leukaemic cells cultured with NDK protein, show an 
increased survival compared with elution buffer control, the error was quite high. This was 
due to the lack of repeats as we only obtained one acute myeloid leukaemia sample, 
therefore repeating this work would decrease the error of the results.  
The acute lymphoid leukaemic cells cultured with NDK protein don’t show a significant 
increase, this was as predicted, because as far as literature suggests, NDK proteins only bind 




lineage, hence the increase in survival of acute myeloid leukaemic cells and not acute 
lymphoid leukaemic cells. However it was hard to comment on the reliability and accuracy 
of these results because only one sample from each leukaemic was treated at this point. 
Even though repeats were done within each sample, the standard deviation for acute 
myeloid leukaemia was quite high, which was suggestive of large variability amongst the 
repeats.  
It could be suggest that bacterial NDK do have an effect on the survival of leukaemic stem 
cells.  This is due to the similarities between the structure and function of the NDK protein 
and the human N23-H1 protein. With the results from (Lilly, et al., 2011) which show that 
NM23-H1 does have an effect on the survival of leukaemic stem cells, suggests that with 
further work, we should get a better idea of the effect of NDKs on leukaemic stem cells.  
10.3 NDK expression at mid-logarithmic and at Stationary growth 
phase.  
Figure 29 shows the expression of NDK from 4 species of bacteria. The results suggest that 
NDK was expressed at a higher level at stationary phase in E. coli and in S. aureus. Bacteria 
spend majority of their life cycle at stationary phase. From the literature we know that NDK 
proteins were used in maintaining the NTP and dNTP pools and play a role in bacterial 
growth.  (Chakrabarty, 1998) NDK were also known to have a secretory function, and play a 
role in the apoptosis of macrophages (Zaborina, et al., 1999). NDK proteins also play a role 
in the pathogenicity of bacteria. The high amount of energy required for bacterial 
pathogenicity can be gained from NDK, when eATP was used from the site of inflammation. 
It has been suggested that eATP was used by the NDK to favour the survival of the 




secreting proteins after infecting the host cell. The higher levels of NDK expressed at 
stationary phase, suggest that this could be a mechanism for pathogencity. The roles played 
by NDK increase the survival chances of E. coli and S. aureus at stationary phase, aswell as 
increasing the pathogencity of the bacteria into the host cell (A Latifi, 2008) (Mangan, 2006). 
The expression of NDK for K. pneumoniae and S. pneumoniae show no significant change at 
mid- logarithmic or at stationary phase. This suggests that NDK may not have a strong 
pathogenic role in K. pneumoniae and S. pneumoniae.  
10.4 NDK gene knockout 
Using the Datsenko and Wanner method it was attempted to knockout the NDK gene from 
Escherichia coli. During the protocol we had successfully transformed our recipient strain 
I364 E. coli cell with pkd46 plasmid and amplified the kanamycin cassette from pkd4 plasmid 
as shown in figure 30. However when screening the colonies, which had been 
electroporated and grown on selective kanamycin plates, they had always shown to be 
unsuccessful. During the electroporation phase of the protocol the NDK gene within the 
I364 E. coli strain, should have been knocked out and replaced by the kanamycin cassette in 
the presence of lambda red recombinase. The amplimer of the kanamycin cassette were 
tagged with nucleotides complimentary to the end sequence of NDK, to enable ‘swapping’ 
to occur more readily.  However after several attempts a NDK gene knockout was not 
successful. 
 It has been stated that the Lambda red recombinase based protocol was dependent on 
several factors, one being the removal of as much primer from the PCR reaction, as primers 




removed as possible, an extra step could be implemented after the amplification of the 
kanamycin cassette, using a PCR clean up kit. The PCR cleanup kits will also remove salt from 
the PCR reaction, which will allow electroporation of higher DNA concentration without 
arcing. Another way of optimising the chances of gene knockout would be to increase the 
concentration of the amplimer DNA; this can be done by using a butanol extraction 
protocol. (Katrina Bepple, 2004) The NDK protein was highly conserved across eukaryotes, 
eubacteria and archaea, (Bilitou, Watson, Gartner, & Ohnuma, 2009) and therefore might 
not be as readily knocked out as other genes, even know the knockout of NDK gene was 
possible, it might only be possible within rigid protocol methods. Given the time, these 
optimisation techniques would have been trialled in the attempt of obtaining a successful 
knockout. However due to time restrictions, a NDK gene knockout was sought from the 
knockout library. 
10.5 NDK knockout growth kinetics  
Growth kinetics analysis was done on the NDK knockout constructs in E. coli I364 and F6 
p86. From figure 32, you can clearly see that the NDK knockout does not affect the growth 
of E. coli, I364 Knockout and F6 p86 knockout both grew to a similar optical density as wild 
type I364. The only difference in the knockout mutants was that their lag phase was slightly 
increased, but without any major consequences to the growth of the bacteria. The results 
obtained within the growth kinetics experiment were what were expected. NDK proteins 
play a role in bacterial growth, however was not an important protein in the growth of 
bacteria, and therefore knocking out the NDK gene should not have an adverse effect on 





10.6 Optimisation of SDM protocol 
The quikchange II site directed mutagenesis kit, Agilent Technologies, was used to produce 
the desired mutations. During the production of site directed mutagenesis, a few stages of 
the protocol had to be optimised, around the instructions given by the manufacturer to 
allow for efficient mutant products. Using the instructions given for thermal cycling, it 
produced a low yield of colonies, and those sequenced were false positives. No protocol for 
mutant production will be sufficient for every site directed mutation desired. Allot depends 
on the area being mutated, how conserved it was and how important the gene was within 
the protein.  To increase yield efficiency, and increase true mutant production, the 
annealing temperature was increased to 68oC and timing increased to 10 minutes and the 
thermal cycling number was increased to 25 cycles, this would allow sufficient annealing of 
the complimentary mutant oligonucleotides. The Dpn I restriction enzyme was also doubled, 
and incubation time was also doubled, to allow for sufficient digestion of parental DNA.  
With these changes, 3 site directed mutations, 2 substitutions and 1 deletion, were 
successfully produced.  
 10.7 Expression and modelling of mutant NDK proteins 
 Whole intracellular and extracellular protein from wild type E. coli, wild type pET15b NDK, 
site directed and knockout mutants were separated on a BOLT 4-12% Bis-Tris Protein Gel, to 
observe any differences in the expression of NDK. The NDK protein was approximately 
19kDa. Shown in figure 35, both the NDK knockout mutants, show a fainter band at 19kDa 
compared with I364 wild type. Because we separated the whole protein from the bacteria, 
we cannot conclusively say whether the knockouts lack NDK or not, the presence of a faint 




Genetically these mutants were NDK knockouts, as shown in figure 30. To determine the 
absence of NDK, western blot analysis was required, using specific antibodies for NDK.  
Comparing the pET15b NDK non-included protein expression with wild type I364, you’d 
expect the NDK band to only be expressed from the bacterial chromosomal DNA and not the 
plasmid, however sometimes these plasmid vectors can leak, and therefore a small amount 
of protein expression may occur from the plasmid too, which explains the stronger band 
present at 19kDa compared with wild type.  
The pET15b induced protein expressed shows a very prominent band at 19kDa both 
intracellularly and extracellularly. All 3 of the site directed mutants, don’t seem to have 
expressed NDK protein as expected. All the site directed NDK mutants were incorporated 
within the pET15b plasmid, same as the pET15b NDK wild type, therefore once induced with 
IPTG, it was expected that the gene inserted within the cloning region was transcribed into 
RNA and then translated. What perhaps was occurring was that there was no reason to 
doubt that the plasmid was not being induced sufficiently, and therefore the gene was being 
transcribed into RNA, however perhaps because of the mutant it was not being translated 
and therefore not being expressed. To determine whether the NDK gene was being 
transcribed, real time PCR will need to be performed using primers specific for NDK. 
Comparing the SDM in I364 strain and in I364 knockout strain, there was no noticeable 
difference between the bands at 19kDa. The SDM’s within the knockout strain will not 
express any NDK from the bacteria’s chromosomal DNA, but the SDM’s within the I364 
strain should also express NDK from the chromosomal DNA.  
SWISS model, an online protein modelling tool was used to model the wild type and the 3 




that was mutated and compared with wild type to determine whether the mutations had 
caused any structural differences. As shown in figure 36, the only mutation to show a 
structural difference was mutant 3 where AA 103 to 105 were deleted, these amino acids 
where part of the KPN loop, a conserved domain, which has been shown to play an 
important role in structural formation of NDK, where the lack of this KPN loop prevents the 
formation of hexameric structural formations. Mutant 1 and 2 where substitutions were 
made, show no structural differences.  
 
10.8 Future Work 
Further investigations could be done on the cytokines released when CD11b+ve cells bind 
bacterial NDK, to discover how they may cause the survival of CD34+ve stem cells. This 
could be done by using a immunoassays or bioassays, however these could be time 
consuming and the sensitivity of the assays are sometimes not great. However in situ 
hybridisation, which is a direct cellular approach, can be used to give high sensitivity in 
detecting cytokines produced when CD11b+ve cells bind bacterial NDK. The binding 
receptor for NM23-H1 and bacterial NDK can be investigated; this could be done by 
computer modelling, circular dichroism or x ray crystallography.  
CD34+ve cell purity techniques need to be reconsidered to obtain optimum purity. A double 
sort could be considered, but cell survival might be hindered. Apart from using high affinity 
microbeads and sorting kits, other techniques could be used. These include; Fluorescent 
Activated Cell sorting (FACs), panning, where anti-CD34 antibodies are bound to the surface 
of the sorting flask. Once the suspension is added to the flask the CD34+ve cells stick to the 




chromatography could also be used to determine a high purity sort. This is dependent on 
biotin-avidin interactions (Carlo, et al., 1995). 
Literature and previous research suggests similarity between NM23 proteins and NDK 
proteins, with identical binding sites. The protein data bank only contain crystal structures 
for Escherichia coli and Staphylococcus aureus, it would be interested to find out how similar 
other bacterial NDK proteins were to NM23-H1 and other bacterial NDK. NM23-H1 and 
NM23-h2 were thought to form fusion proteins; could bacterial NDK proteins bind to 
NM23? What would the affect be on the survival of normal and leukaemic stem cells? Also 
would a combined assay containing NM23 and bacterial NDK convey altered survival of 
leukaemic and/or ‘normal’ haemopoietic stem cells? 
The project was undertaken to develop a further understanding and characterisation of 
Bacterial NDK proteins. Current literature suggests that within the NDK protein, several 
conserved domains, which have already been mutated, have shown to influence the 
structural stability of the NDK protein, (Sundin, et al., 1996) as well as a larger percentage 
prone to mis-pairment.  (Miller, et al., 2002).  This project looked at 4 bacterial species 
which were known to cause infections in cancer patients, to determine whether there was a 
difference in expression of NDK between these bacteria, and whether a mtation in the 
conserved domains of NDK influence the structure, expression and function of bacterial NDK 
protein, as literature may suggest.  
The work undertaken in this project has provided us with the tools to further the research 
into bacterial NDK and their affects on the survival of leukemic and haemopoietic stem cells. 




the survival of haemopoietic and leukaemic stem cells, however more repeats need to be 
done to determine an accurate and reliable result.  
The protein expression results have suggested that the biology of the mutants has been 
disrupted, however further analysis was required to determine where this disruption has 
occurred. Performing real-time PCR on the SDM’s to determine whether the NDK gene was 
being transcribed into RNA, will determine whether the defect was within transcription or in 
translation and expression of the NDK protein.  
The protein modelling has suggested that mutant 3 has affected the structure of NDK by 
disrupting the KPN loop. To further conclude this finding, undertaking circular dichroism to 
determine the structure of the mutant by looking at the difference in left and right circular 
polarised light, compared with wild type NDK protein, would backup the findings already 
obtained. (Giartosia, et al., 1996) (Sandra Jeudy, 2009) 
Once the structure and biology of the mutants were confirmed, further analysis can be done 
to determine how these mutants affect haemopoietic and leukaemic stem cells, by carrying 
out survival assays, similar to those done on wild type NDK proteins. This will give an 
indication whether the mutations have affected the survival mechanism of NDK proteins.  
Once the characterisation and survival mechanisms have been proven in vitro, in vivo 
testing was necessary to determine the affects of bacterial NDK proteins within a real-time 
setting. Myelodsyplastic mice have been produced, which were pre-disposed to pre-
leukaemia, an observation can be made to see whether the addition of bacteria containing 





The survival of leukaemic cells by bacterial NDK could be a significant factor in patient 
treatment and therapy. With bacterial infections being a high possibility within leukaemic 
patients, and the suggestive increase in survival of leukaemic cells by bacterial NDK, can it 
be possible that bacterial infections may have a bigger impact on leukaemic patients, and 





11.1 Appendix 1. Recipes and Buffers 
 
4x Gel Loading Buffer 
3.7 ml dH2O 
1.25 ml 0.5 M Tris HCl pH 6.8  
2.5 ml glycerol (40%) 
2.0 ml 10% SDS (2%) 
0.5 ml 2-β-mercaptoethanol-Brilliant blue 
 
1% Agarose Gel  
1 g agarose dissolve in 100ml 1×TBE buffer. 
Heat to dissolve. 
 Cool and add 3 μl ethidium bromide 
 
Lysogeny Broth (LB) 
20 g dissolve in 1L dH2O 
 
Lysogeny Agar 









Acrylamide Gel- Resolving Layer 
3.2 ml dH2O 
2.5 ml 1.5 M Tris HCl pH 8.8 
4.2 ml ProtoGel (30% (w/v) acrylamide: 0.8% (w/v) Bis-acrylamide stack solution 
(37.5:1) 
100 μl 10% SDS 
50 μl 10% Ammonium persulphate 
3.3 μl TEMED 
 
Acrylamide Gel – Stacking layer 
2.03 ml dH2O 
830 μl 0.5 M Tris HCl pH 6.8 
440 μl ProtoGel (30% (w/v) acrylamide: 0.8% (w/v) Bis-acrylamide stack solution 
(37.5:1) 
66 μl 10% SDS 
16.7 μl 10% Ammonium persulphate 
1.7 μl TEMED 
 
10x Running Buffer 
30 g Tris (250 mM) 
144 g Glycine (1.92 M) 
10 g SDS (1%)  








1.5M TRIS pH 8.8 
90.8 g TRIS 
Dissolve in 400 ml dH2O pH to 8.8 
Make up to 500 ml 
 
0.5M TRIS pH6.8 
30.3 g TRIS 
Dissolve in 400 ml dH2O, pH to 6.8 
Make up to 500 ml  
 
1x TBE Buffer 
10.8 g TRIS 
5.5 g Boric acid 
4 ml 5 M EDTA pH 8.0 
Make up to 1L H2O 
 
Transfer Buffer 
7.575 g TRis (25 mM) 
36 g glycine (192 mM) 
500 ml methanol (20%) 










40 ml 1.0 M tris HCl pH 7.6 
16 g NaCl 
2 ml Tween20 
Make up to 2L dH2O 
 
Coomassie blue stain 
50% (v/v) methanol 
10% (v/v) acetic acid 
0.05% (w/v) Coomassie Brilliant blue 
 
Equilibrium buffer 
50mM sodium phosphate pH 8 
0.3M sodium chloride 
10mM imidazole in H2O 
 
Macs Buffer 
2 mM EDTA 




1% formaldehyde (v/v) 
2% FBS (v/v) 





Giemsa Buffer pH 7 
8 mM KH2PO4 





11.2 Appendix 2. cDNA expression Primer Designs 
 
Sequences of ndk  
 























Forward.  ACCGTTCTTTGATGGTCTGG 
Reverse. GATTCGACGGAATCAGAACC 
   
201 bp 50 C annealing. 
 
 




























237 bp 50 C annealing 
 























Forward.  CGCAATGGTAGTTGAAGGTG 
Reverse.    GCATCACGTGGTGAAGCATA    
222 bp 50 C annealing 





















Forward.  TGAAGTGTTAAAGCGCATCG 
Reverse.  GCTTCTTCTGGACGAGTTGC 
257 bp 50 C annealing 
      
 
 
11.3 Appendix 4. Bacterial NDK expressions at mid logarithmic and stationary growth phase calculation 
             
             
 
E.coli 
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Log Stat Log Stat Log Stat Log Stat 
   
 
Control 74.6 108.6 563.9 337.7 642.7 485.4 318.7 325.5 
   
 
NDK 28.5 123.1 37.1 18.6 266.5 327.4 68.4 69.8 














    
             
 
NDKlog 100   100   100   100 


















































2   
83.7163
1   
162.663
5   
99.9149
3 















    
 
 
      
 
 
11.5 Appendix 5. Knockout Production Primer Design  
 
E. coli ndk inactivation primers 
 





























      
 
11.5 Appendix 5. Site Directed Mutagensis Primer Design 
 














a78c 39 79.50°C -45.65 kcal/mole 1.5% 
a78c_antisense 39 79.50°C -48.58 kcal/mole 2.8% 
 




a31g_a32c_c34g 46 78.13°C -51.84 kcal/mole 8.0% 





‘G’ 79 to ‘A’79 
g236c 5'-gtttccgtgctggaagctgaaaacgccgttcag-3' 
g236c_antisense 5'-ctgaacggcgttttcagcttccagcacggaaac-3' 
g236c 33 80.38°C -42.72 kcal/mole 7.0% 
g236c_antisense 33 80.38°C -43.43 kcal/mole 9.4% 
 
 
Kpn Loop deletion 
 




del307-315 32 81.63°C -43.92 kcal/mole 36.3% 
del307-315-antisense 32 81.63°C -42.62 kcal/mole 37.9% 
 
‘H’ 117 to ‘A’ 117 
Primer Name Primer Sequence (5' to 3') 
c349g_a350c 5'-gaccgaaaacggtaccgccggttctgattccgtc-3' 
c349g_a350c_antisense 5'-gacggaatcagaaccggcggtaccgttttcggtc-3' 
c349g_a350c 34 78.68°C -45.47 kcal/mole 9.6% 
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